feature_name,cui,cui_nomenclature,cui_def,KG_Hits,sim_score,feature_level_min_kg_hits,feature_level_sum_kg_hits,feature_level_avg_kg_hits,feature_importance,p_val,corr,MutualInfoTarget,raw_name,F.Split-Lift (y==1),F.Split-Support,F.Split-Feature Split,sim_score_target_feat,sim_score_target_cui,shortest_path_length
Urate,C0729829,Urate level - finding,Urate level - finding. ,0,0.759,0.0,0.0,0.0,0.8095,0.0,0.214,0.0667,Urate,4.68,1792,2.10 <= Urate < 2.90,0.11,0.11,2
Urate,C0935936,Urate,"Urate. 2,6,8-trioxypurine.",0,0.778,0.0,0.0,0.0,0.8095,0.0,0.214,0.0667,Urate,4.68,1792,2.10 <= Urate < 2.90,0.11,0.11,2
medication allopurinol,C0002144,allopurinol,allopurinol. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.,0,0.884,0.0,0.0,0.0,0.3057,0.0,0.392,0.0414,Treatment/medication code | Array 0__allopurinol,6.97,3425,Treatment/medication code | Array 0__allopurinol >= 0.50,0.07,0.07,2
Number of self-reported non-cancer illnesses,C2700446,Self-Report,Self-Report. An individual's perspective or subjective interpretation of an event or information.,0,0.411,0.0,0.0,0.0,0.0883,0.0,0.138,0.0101,Number of self-reported non-cancer illnesses,2.36,1149,Number of self-reported non-cancer illnesses >= 3.00,0.08,0.08,2
Home area population density - urban or rural Scotland - Large Urban Area,C0178587,density,density. The amount of something per unit size.,0,0.243,0.0,0.0,0.0,0.0804,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.03,0.08,2
Home area population density - urban or rural Scotland - Large Urban Area,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.319,0.0,0.0,0.0,0.0804,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.03,0.08,4
Home area population density - urban or rural Scotland - Large Urban Area,C0724128,Urban tradename,Urban tradename. ,0,0.15,0.0,0.0,0.0,0.0804,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.03,0.08,99
Home area population density - urban or rural Scotland - Large Urban Area,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.387,0.0,0.0,0.0,0.0804,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.03,0.08,99
Home area population density - urban or rural Scotland - Large Urban Area,C0549177,Large,"Large. Of considerable or relatively great size, extent, or capacity.",0,0.273,0.0,0.0,0.0,0.0804,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.03,0.08,2
Home area population density - urban or rural Scotland - Large Urban Area,C1416798,LARGE1 gene,LARGE1 gene. ,0,0.184,0.0,0.0,0.0,0.0804,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.03,0.08,2
gout,C0018099,Gout,"Gout. Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.",0,0.708,0.0,0.0,0.0,0.0604,0.0,0.223,0.0132,"Non-cancer illness code, self-reported | Array 1__gout",6.78,1215,"Non-cancer illness code, self-reported | Array 1__gout >= 0.50",0.0,0.0,2
Apolipoprotein A Blood biochemistry,C0003592,Apolipoproteins A,"Apolipoproteins A. Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE.",0,0.809,0.0,0.0,0.0,0.054,0.0127,-0.012,0.0102,Apolipoprotein A Blood biochemistry,1.15,7980,-2.10 <= Apolipoprotein A Blood biochemistry < -1.20,-0.07,-0.07,2
Apolipoprotein A Blood biochemistry,C0085201,Apolipoprotein A-I,"Apolipoprotein A-I. The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE.",0,0.775,0.0,0.0,0.0,0.054,0.0127,-0.012,0.0102,Apolipoprotein A Blood biochemistry,1.15,7980,-2.10 <= Apolipoprotein A Blood biochemistry < -1.20,-0.07,-0.07,2
Apolipoprotein A Blood biochemistry,C0003591,Apolipoproteins,Apolipoproteins. Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.,0,0.693,0.0,0.0,0.0,0.054,0.0127,-0.012,0.0102,Apolipoprotein A Blood biochemistry,1.15,7980,-2.10 <= Apolipoprotein A Blood biochemistry < -1.20,-0.07,-0.07,2
LDL direct Blood biochemistry,C0023823,Low-Density Lipoproteins,"Low-Density Lipoproteins. A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues.",0,0.715,0.0,0.0,0.0,0.0458,0.0,-0.06,0.0297,LDL direct Blood biochemistry,1.34,9470,-2.70 <= LDL direct Blood biochemistry < -1.30,-0.12,-0.12,2
LDL direct Blood biochemistry,C0023169,LDL-1,LDL-1. Low-density lipoprotein particles with density between 1.019 and 1.045 g/ml.,0,0.612,0.0,0.0,0.0,0.0458,0.0,-0.06,0.0297,LDL direct Blood biochemistry,1.34,9470,-2.70 <= LDL direct Blood biochemistry < -1.30,-0.12,-0.12,2
LDL direct Blood biochemistry,C0023170,LDL-2,LDL-2. Low-density lipoprotein particles with density between 1.045 and 1.063 g/ml.,0,0.611,0.0,0.0,0.0,0.0458,0.0,-0.06,0.0297,LDL direct Blood biochemistry,1.34,9470,-2.70 <= LDL direct Blood biochemistry < -1.30,-0.12,-0.12,2
"Long-standing illness, disability or infirmity",C0231170,Disability,Disability. Any physical or mental impairment that interferes with an individual's ability to perform desired activities.,0,0.495,0.0,0.0,0.0,0.0384,0.0,-0.087,0.0038,"Long-standing illness, disability or infirmity_No",1.28,42073,"Long-standing illness, disability or infirmity_No < 0.50",0.0,0.0,2
"Long-standing illness, disability or infirmity",C0231172,handicapping condition,handicapping condition. ,0,0.617,0.0,0.0,0.0,0.0384,0.0,-0.087,0.0038,"Long-standing illness, disability or infirmity_No",1.28,42073,"Long-standing illness, disability or infirmity_No < 0.50",0.0,0.0,2
Haemoglobin concentration,C0019016,Hemoglobin A,Hemoglobin A. Normal adult human hemoglobin. The globin moiety consists of two alpha and two beta chains.,0,0.479,0.0,1.0,0.3,0.0357,0.0,-0.01,0.0064,Haemoglobin concentration,1.64,1465,-2.80 <= Haemoglobin concentration < -2.10,-0.01,-0.01,2
Haemoglobin concentration,C0019020,Hemoglobin C,Hemoglobin C. A commonly occurring abnormal hemoglobin in which lysine replaces a glutamic acid residue at the sixth position of the beta chains. It results in reduced plasticity of erythrocytes.,0,0.614,0.0,1.0,0.3,0.0357,0.0,-0.01,0.0064,Haemoglobin concentration,1.64,1465,-2.80 <= Haemoglobin concentration < -2.10,-0.01,-0.01,2
Coffee intake,C1512806,Intake,"Intake. The process of taking in a substance, especially by eating or drinking, or the quantities thereof; admittance of people to a place or organization at a particular time.",0,0.474,0.0,1.0,0.3,0.0327,0.0,-0.049,0.0014,Coffee intake,1.17,25859,-1.20 <= Coffee intake < -0.71,0.06,0.19,99
Coffee intake,C3251814,Fluid Intake Measurement,Fluid Intake Measurement. Actions performed to measure the amount of fluid volume taken into the body,0,0.363,0.0,1.0,0.3,0.0327,0.0,-0.049,0.0014,Coffee intake,1.17,25859,-1.20 <= Coffee intake < -0.71,0.06,0.19,99
Urea,C0041942,urea,urea. A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.,0,0.778,0.0,0.0,0.0,0.0321,0.0,0.092,0.0172,Urea,2.39,1761,1.90 <= Urea < 2.70,0.01,0.01,2
Microalbumin in urine,C2362049,Microalbumin,"Microalbumin. Albumin protein in urine samples, which is a marker for kidney dysfunction. Persistently elevated concentrations of albumin in the urine can be diagnostic for kidney damage caused by diabetes, high blood pressure, heart failure, cirrhosis, or lupus.",0,0.856,0.0,0.0,0.0,0.0307,0.0,0.016,0.0218,Microalbumin in urine,2.64,1415,0.85 <= Microalbumin in urine < 7.50,-0.06,-0.06,2
Microalbumin in urine,C0042036,Urine,"Urine. Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.",0,0.597,0.0,0.0,0.0,0.0307,0.0,0.016,0.0218,Microalbumin in urine,2.64,1415,0.85 <= Microalbumin in urine < 7.50,-0.06,-0.06,2
Microalbumin in urine,C0042037,In Urine,"In Urine. Used for the presence or analysis of substances in the urine, and also for the examination of, or changes in, the urine in disease.",0,0.516,0.0,0.0,0.0,0.0307,0.0,0.016,0.0218,Microalbumin in urine,2.64,1415,0.85 <= Microalbumin in urine < 7.50,-0.06,-0.06,99
Z51.5 - Palliative care,C0557533,Hospice and Palliative Care Nursing,"Hospice and Palliative Care Nursing. A nursing specialty concerned with care of patients facing serious or life-threatening illnesses. The goal of palliative nursing is to prevent and relieve suffering, and to support the best possible quality of life for patients and their families. Hospice nursing is palliative care for people in their final stages of life.",0,0.529,0.0,1.0,0.5,0.0241,0.7013,-0.004,0.0013,Z51.5 - Palliative care,1.02,90035,-0.46 <= Z51.5 - Palliative care < 0.85,0.18,0.18,3
(MS) multiple sclerosis genetic risk,C0026221,Mississippi (geographic location),"Mississippi (geographic location). State bounded on the north by Tennessee, on the east by Alabama, on the south by Louisiana and Gulf of Mexico, and on the west by Arkansas and Louisiana.",0,0.234,0.0,0.0,0.0,0.0227,0.0011,0.011,0.3067,(MS) multiple sclerosis genetic risk,1.18,2699,(MS) multiple sclerosis genetic risk >= 2.10,0.01,0.01,99
(MS) multiple sclerosis genetic risk,C0026269,Mitral Valve Stenosis,"Mitral Valve Stenosis. Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.",0,0.244,0.0,0.0,0.0,0.0227,0.0011,0.011,0.3067,(MS) multiple sclerosis genetic risk,1.18,2699,(MS) multiple sclerosis genetic risk >= 2.10,0.01,0.01,2
(MS) multiple sclerosis genetic risk,C0026769,Multiple Sclerosis,"Multiple Sclerosis. An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)",0,0.685,0.0,0.0,0.0,0.0227,0.0011,0.011,0.3067,(MS) multiple sclerosis genetic risk,1.18,2699,(MS) multiple sclerosis genetic risk >= 2.10,0.01,0.01,2
(MS) multiple sclerosis genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.602,0.0,0.0,0.0,0.0227,0.0011,0.011,0.3067,(MS) multiple sclerosis genetic risk,1.18,2699,(MS) multiple sclerosis genetic risk >= 2.10,0.01,0.01,2
Z92.1 - Personal history of long-term (current) use of anticoagulants,C0262926,Medical History,"Medical History. A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.",0,0.399,0.0,0.0,0.0,0.0187,0.0112,0.001,0.0017,Z92.1 - Personal history of long-term (current) use of anticoagulants,1.66,2685,Z92.1 - Personal history of long-term (current) use of anticoagulants >= 1.30,0.09,0.11,2
Z92.1 - Personal history of long-term (current) use of anticoagulants,C0424945,Social and personal history,Social and personal history. ,0,0.298,0.0,0.0,0.0,0.0187,0.0112,0.001,0.0017,Z92.1 - Personal history of long-term (current) use of anticoagulants,1.66,2685,Z92.1 - Personal history of long-term (current) use of anticoagulants >= 1.30,0.09,0.11,99
Z92.1 - Personal history of long-term (current) use of anticoagulants,C0003280,Anticoagulants,Anticoagulants. Agents that prevent BLOOD CLOTTING.,0,0.52,0.0,0.0,0.0,0.0187,0.0112,0.001,0.0017,Z92.1 - Personal history of long-term (current) use of anticoagulants,1.66,2685,Z92.1 - Personal history of long-term (current) use of anticoagulants >= 1.30,0.09,0.11,2
Arthropathy NOS,C0022408,Arthropathy,Arthropathy. Diseases involving the JOINTS.,0,0.952,0.0,0.0,0.0,0.0168,0.0952,-0.004,0.0009,Arthropathy NOS,1.52,1456,-4.50 <= Arthropathy NOS < -1.90,-0.06,-0.06,2
Triglycerides,C0041004,Triglycerides,Triglycerides. An ester formed from GLYCEROL and three fatty acid groups.,0,0.904,0.0,0.0,0.0,0.0165,0.0,0.084,0.0394,Triglycerides,1.92,2452,Triglycerides >= 2.50,0.03,0.03,2
Triglycerides,C0202236,Triglycerides measurement,Triglycerides measurement. A quantitative measurement of the amount of triglyceride present in a sample.,0,0.808,0.0,0.0,0.0,0.0165,0.0,0.084,0.0394,Triglycerides,1.92,2452,Triglycerides >= 2.50,0.03,0.03,99
SHBG,C0036883,Sex Hormone-Binding Globulin,"Sex Hormone-Binding Globulin. A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.",0,0.45,0.0,0.0,0.0,0.0145,0.0,-0.071,0.0511,SHBG,1.68,2712,SHBG < -1.40,0.05,0.05,2
SHBG,C0312446,Somatotropin binding globulin,Somatotropin binding globulin. ,0,0.518,0.0,0.0,0.0,0.0145,0.0,-0.071,0.0511,SHBG,1.68,2712,SHBG < -1.40,0.05,0.05,99
SHBG,C1366439,SHBG gene,SHBG gene. This gene is involved in the regulation of steroid hormones.,0,0.622,0.0,0.0,0.0,0.0145,0.0,-0.071,0.0511,SHBG,1.68,2712,SHBG < -1.40,0.05,0.05,2
Birth weight,C0005612,Birth Weight,Birth Weight. The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.,0,0.866,0.0,0.0,0.0,0.0142,0.0,-0.017,0.0017,Birth weight,1.03,72146,-3.70 <= Birth weight < 0.07,-0.14,-0.14,2
Birth weight,C0024032,Low Birth Weights,Low Birth Weights. A birth weight that is less than 2500 grams.,0,0.722,0.0,0.0,0.0,0.0142,0.0,-0.017,0.0017,Birth weight,1.03,72146,-3.70 <= Birth weight < 0.07,-0.14,-0.14,2
Chronic renal failure [CKD],C0022661,"Kidney Failure, Chronic","Kidney Failure, Chronic. The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.",0,0.805,0.0,0.0,0.0,0.0137,0.0657,0.025,0.0027,Chronic renal failure [CKD],0.97,89920,-0.59 <= Chronic renal failure [CKD] < 0.34,0.02,0.02,2
Chronic renal failure [CKD],C1561643,Chronic Kidney Diseases,Chronic Kidney Diseases. Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.,0,0.72,0.0,0.0,0.0,0.0137,0.0657,0.025,0.0027,Chronic renal failure [CKD],0.97,89920,-0.59 <= Chronic renal failure [CKD] < 0.34,0.02,0.02,2
Chronic renal failure [CKD],C2316810,Chronic kidney disease stage 5,Chronic kidney disease stage 5. Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.,0,0.532,0.0,0.0,0.0,0.0137,0.0657,0.025,0.0027,Chronic renal failure [CKD],0.97,89920,-0.59 <= Chronic renal failure [CKD] < 0.34,0.02,0.02,2
(HDL) high density lipoprotein cholesterol genetic risk,C0023821,High Density Lipoproteins,"High Density Lipoproteins. A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.",0,0.479,0.0,0.0,0.0,0.0136,0.0,-0.021,0.307,(HDL) high density lipoprotein cholesterol genetic risk,1.15,7182,(HDL) high density lipoprotein cholesterol genetic risk < -1.40,0.03,0.03,2
(HDL) high density lipoprotein cholesterol genetic risk,C3715113,HSD11B1 wt Allele,"HSD11B1 wt Allele. Human HSD11B1 wild-type allele is located within 1q32-q41 and is approximately 49 kb in length. This allele, which encodes corticosteroid 11-beta-dehydrogenase isozyme 1 protein, plays a role in the metabolism of cortisol. Mutation of the gene is associated with cortisone reductase deficiency.",0,0.321,0.0,0.0,0.0,0.0136,0.0,-0.021,0.307,(HDL) high density lipoprotein cholesterol genetic risk,1.15,7182,(HDL) high density lipoprotein cholesterol genetic risk < -1.40,0.03,0.03,2
(HDL) high density lipoprotein cholesterol genetic risk,C0062709,"Lipoproteins, HDL2","Lipoproteins, HDL2. Low-density subclass of the high-density lipoproteins, with particle sizes between 8 to 13 nm.",0,0.423,0.0,0.0,0.0,0.0136,0.0,-0.021,0.307,(HDL) high density lipoprotein cholesterol genetic risk,1.15,7182,(HDL) high density lipoprotein cholesterol genetic risk < -1.40,0.03,0.03,2
(HDL) high density lipoprotein cholesterol genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.753,0.0,0.0,0.0,0.0136,0.0,-0.021,0.307,(HDL) high density lipoprotein cholesterol genetic risk,1.15,7182,(HDL) high density lipoprotein cholesterol genetic risk < -1.40,0.03,0.03,2
Apolipoprotein A1,C0085201,Apolipoprotein A-I,"Apolipoprotein A-I. The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE.",0,0.887,0.0,0.0,0.0,0.0133,0.007,0.004,0.0564,Apolipoprotein A1,1.31,2405,2.40 <= Apolipoprotein A1 < 5.30,-0.04,-0.04,2
Apolipoprotein A1,C1412468,APOA1 gene,APOA1 gene. This gene is involved in cholesterol transport and metabolism.,0,0.758,0.0,0.0,0.0,0.0133,0.007,0.004,0.0564,Apolipoprotein A1,1.31,2405,2.40 <= Apolipoprotein A1 < 5.30,-0.04,-0.04,2
Apolipoprotein A1,C1677784,"APOA1 protein, human","APOA1 protein, human. Apolipoprotein A-I (267 aa, ~31 kDa) is encoded by the human APOA1 gene. This protein is involved in the transport and metabolism of cholesterol.",0,0.845,0.0,0.0,0.0,0.0133,0.007,0.004,0.0564,Apolipoprotein A1,1.31,2405,2.40 <= Apolipoprotein A1 < 5.30,-0.04,-0.04,99
Home area population density - urban or rural Scotland - Other Urban Area,C0178587,density,density. The amount of something per unit size.,0,0.276,0.0,0.0,0.0,0.0126,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.03,0.05,2
Home area population density - urban or rural Scotland - Other Urban Area,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.339,0.0,0.0,0.0,0.0126,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.03,0.05,4
Home area population density - urban or rural Scotland - Other Urban Area,C0724128,Urban tradename,Urban tradename. ,0,0.187,0.0,0.0,0.0,0.0126,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.03,0.05,99
Home area population density - urban or rural Scotland - Other Urban Area,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.386,0.0,0.0,0.0,0.0126,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.03,0.05,99
Home area population density - urban or rural Scotland - Other Urban Area,C0178876,urban area,"urban area. of, relating to, or located in a city area.",0,0.334,0.0,0.0,0.0,0.0126,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.03,0.05,2
(RA) rheumatoid arthritis genetic risk,C0003873,Rheumatoid Arthritis,"Rheumatoid Arthritis. A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.",0,0.659,0.0,0.0,0.0,0.0122,0.1424,0.003,0.3073,(RA) rheumatoid arthritis genetic risk,1.09,6905,1.50 <= (RA) rheumatoid arthritis genetic risk < 3.70,0.08,0.08,2
(RA) rheumatoid arthritis genetic risk,C0038013,Ankylosing spondylitis,"Ankylosing spondylitis. A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.",0,0.422,0.0,0.0,0.0,0.0122,0.1424,0.003,0.3073,(RA) rheumatoid arthritis genetic risk,1.09,6905,1.50 <= (RA) rheumatoid arthritis genetic risk < 3.70,0.08,0.08,2
(RA) rheumatoid arthritis genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.602,0.0,0.0,0.0,0.0122,0.1424,0.003,0.3073,(RA) rheumatoid arthritis genetic risk,1.09,6905,1.50 <= (RA) rheumatoid arthritis genetic risk < 3.70,0.08,0.08,2
Essential hypertension,C0085580,Essential Hypertension,"Essential Hypertension. Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500",0,0.751,0.0,0.0,0.0,0.0122,0.0,-0.021,0.0038,Essential hypertension,1.68,5491,-3.90 <= Essential hypertension < -1.50,0.01,0.01,2
Atrial fibrillation and flutter,C0004238,Atrial Fibrillation,"Atrial Fibrillation. Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.",0,0.828,0.0,0.0,0.0,0.012,0.1973,-0.001,0.002,Atrial fibrillation and flutter,2.0,1394,-5.10 <= Atrial fibrillation and flutter < -1.20,0.0,0.0,2
Atrial fibrillation and flutter,C0344434,Atrial Fibrillation by ECG Finding,"Atrial Fibrillation by ECG Finding. An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. (CDISC)",0,0.653,0.0,0.0,0.0,0.012,0.1973,-0.001,0.002,Atrial fibrillation and flutter,2.0,1394,-5.10 <= Atrial fibrillation and flutter < -1.20,0.0,0.0,99
Atrial fibrillation and flutter,C0016385,Cardiac Flutter,Cardiac Flutter. ,0,0.783,0.0,0.0,0.0,0.012,0.1973,-0.001,0.002,Atrial fibrillation and flutter,2.0,1394,-5.10 <= Atrial fibrillation and flutter < -1.20,0.0,0.0,2
Atrial fibrillation and flutter,C2242390,Flutter (respiratory device),Flutter (respiratory device). ,0,0.541,0.0,0.0,0.0,0.012,0.1973,-0.001,0.002,Atrial fibrillation and flutter,2.0,1394,-5.10 <= Atrial fibrillation and flutter < -1.20,0.0,0.0,99
Albumin,C0001924,Albumins,"Albumins. Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating.",0,0.835,0.0,0.0,0.0,0.0116,0.0785,-0.003,0.0705,Albumin,1.36,1072,Albumin < -2.80,-0.05,-0.05,2
Albumin,C1412332,ALB gene,ALB gene. ,0,0.596,0.0,0.0,0.0,0.0116,0.0785,-0.003,0.0705,Albumin,1.36,1072,Albumin < -2.80,-0.05,-0.05,2
Testosterone,C0039601,testosterone,"testosterone. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.",0,0.768,0.0,0.0,0.0,0.0115,0.2638,-0.016,0.0911,Testosterone,1.41,7043,-1.40 <= Testosterone < -0.47,0.06,0.06,2
Testosterone,C4721537,Therapeutic Testosterone,"Therapeutic Testosterone. A synthetic form of the endogenous androgenic steroid testosterone. In vivo, testosterone is irreversibly converted to dihydrotestosterone (DHT) in target tissues by the enzyme 5-alpha reductase. Testosterone or DHT ligand-androgen receptor complexes act as transcription factor complexes, stimulating the expression of various responsive genes. DHT binds with higher affinity to androgen receptors than testosterone, activating gene expression more efficiently. In addition, testosterone is irreversibly converted to estradiol by the enzyme complex aromatase, particularly in the liver and adipose tissue. Testosterone and DHT promote the development and maintenance of male sex characteristics related to the internal and external genitalia, skeletal muscle, and hair follicles; estradiol promotes epiphyseal maturation and bone mineralization. Due to rapid metabolism by the liver, therapeutic testosterone is generally administered as an ester derivative.",0,0.646,0.0,0.0,0.0,0.0115,0.2638,-0.016,0.0911,Testosterone,1.41,7043,-1.40 <= Testosterone < -0.47,0.06,0.06,99
Testosterone,C0523912,Testosterone measurement,Testosterone measurement. The determination of the amount of testosterone present in a sample.,0,0.758,0.0,0.0,0.0,0.0115,0.2638,-0.016,0.0911,Testosterone,1.41,7043,-1.40 <= Testosterone < -0.47,0.06,0.06,2
Age high blood pressure diagnosed,C0001779,Age,Age. How long something has existed; elapsed time since birth.,0,0.375,0.0,0.0,0.0,0.0111,0.0,-0.112,0.0061,Age high blood pressure diagnosed_None,1.41,36638,Age high blood pressure diagnosed_None < 0.50,0.04,0.04,2
Sex,C0009253,Coitus,"Coitus. The sexual union of a male and a female, a term used for human only.",0,0.731,0.0,0.0,0.0,0.011,0.0,-0.034,0.0006,Sex,1.05,72375,Sex < 0.71,-0.11,-0.11,2
Sex,C0036864,Sex Behavior,Sex Behavior. Sexual activities of humans.,0,0.666,0.0,0.0,0.0,0.011,0.0,-0.034,0.0006,Sex,1.05,72375,Sex < 0.71,-0.11,-0.11,2
Sex,C0079399,Gender,Gender. Socially-constructed identity of male or female.,0,0.391,0.0,0.0,0.0,0.011,0.0,-0.034,0.0006,Sex,1.05,72375,Sex < 0.71,-0.11,-0.11,2
Direct bilirubin,C0005437,Bilirubin,Bilirubin. A bile pigment that is a degradation product of HEME.,0,0.81,0.0,0.0,0.0,0.0108,0.0,0.032,0.0043,Direct bilirubin,1.29,2668,2.20 <= Direct bilirubin < 6.50,-0.03,-0.03,2
Direct bilirubin,C5241078,bilirubin preparation,bilirubin preparation. ,0,0.903,0.0,0.0,0.0,0.0108,0.0,0.032,0.0043,Direct bilirubin,1.29,2668,2.20 <= Direct bilirubin < 6.50,-0.03,-0.03,99
(CVD) cardiovascular disease genetic risk,C0007222,Cardiovascular Diseases,Cardiovascular Diseases. Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.,0,0.511,0.0,0.0,0.0,0.0097,0.0,0.028,0.3075,(CVD) cardiovascular disease genetic risk,1.09,30971,0.38 <= (CVD) cardiovascular disease genetic risk < 3.00,0.08,0.08,2
(CVD) cardiovascular disease genetic risk,C0007820,Cerebrovascular Disorders,"Cerebrovascular Disorders. A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.",0,0.332,0.0,0.0,0.0,0.0097,0.0,0.028,0.3075,(CVD) cardiovascular disease genetic risk,1.09,30971,0.38 <= (CVD) cardiovascular disease genetic risk < 3.00,0.08,0.08,2
(CVD) cardiovascular disease genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.737,0.0,0.0,0.0,0.0097,0.0,0.028,0.3075,(CVD) cardiovascular disease genetic risk,1.09,30971,0.38 <= (CVD) cardiovascular disease genetic risk < 3.00,0.08,0.08,2
(HT) hypertension genetic risk,C0677607,Hashimoto Disease,Hashimoto Disease. An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.,0,0.258,0.0,0.0,0.0,0.0091,0.0,0.035,0.3074,(HT) hypertension genetic risk,1.23,10112,(HT) hypertension genetic risk >= 1.20,0.02,0.02,2
(HT) hypertension genetic risk,C0020538,Hypertensive disease,"Hypertensive disease. Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.",0,0.613,0.0,0.0,0.0,0.0091,0.0,0.035,0.3074,(HT) hypertension genetic risk,1.23,10112,(HT) hypertension genetic risk >= 1.20,0.02,0.02,2
(HT) hypertension genetic risk,C0235222,Diastolic hypertension,Diastolic hypertension. Hypertension characterized diastolic blood pressure greater than 90 mmHg on two occasions.,0,0.385,0.0,0.0,0.0,0.0091,0.0,0.035,0.3074,(HT) hypertension genetic risk,1.23,10112,(HT) hypertension genetic risk >= 1.20,0.02,0.02,2
(HT) hypertension genetic risk,C1696708,Prehypertension,"Prehypertension. Blood pressure levels that are between normotension and hypertension. Individuals with prehypertension are at a higher risk for developing cardiovascular diseases. Generally, prehypertension is defined as SYSTOLIC PRESSURE of 131-139 mm Hg and/or DIASTOLIC PRESSURE of 81-89 when the optimal is 120/80 mm Hg. For diabetics and other metabolism diseases the prehypertension is around 110-129/70-79 mm Hg.",0,0.622,0.0,0.0,0.0,0.0091,0.0,0.035,0.3074,(HT) hypertension genetic risk,1.23,10112,(HT) hypertension genetic risk >= 1.20,0.02,0.02,2
(HT) hypertension genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.691,0.0,0.0,0.0,0.0091,0.0,0.035,0.3074,(HT) hypertension genetic risk,1.23,10112,(HT) hypertension genetic risk >= 1.20,0.02,0.02,2
(T2D) type 2 diabetes genetic risk,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent","Diabetes Mellitus, Non-Insulin-Dependent. A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.",0,0.606,0.0,0.0,0.0,0.0091,0.0,0.02,0.3071,(T2D) type 2 diabetes genetic risk,1.11,10538,(T2D) type 2 diabetes genetic risk >= 1.20,0.03,0.03,2
(T2D) type 2 diabetes genetic risk,C3854130,T2d,"T2d. A TNM stage finding term that refers to choroidal and ciliary body melanoma or conjunctival melanoma TNM staging. For choroidal and ciliary body melanoma it means tumor size category 2 with ciliary body involvement and extraocular extension 5 mm or less in largest diameter. For conjunctival melanoma it means caruncular tumor, and more than 1 quadrant of the nonbulbar conjunctiva involved. (from AJCC 8th Ed.)",0,0.171,0.0,0.0,0.0,0.0091,0.0,0.02,0.3071,(T2D) type 2 diabetes genetic risk,1.11,10538,(T2D) type 2 diabetes genetic risk >= 1.20,0.03,0.03,99
(T2D) type 2 diabetes genetic risk,C0011854,"Diabetes Mellitus, Insulin-Dependent","Diabetes Mellitus, Insulin-Dependent. A chronic condition characterized by minimal or absent production of insulin by the pancreas.",0,0.567,0.0,0.0,0.0,0.0091,0.0,0.02,0.3071,(T2D) type 2 diabetes genetic risk,1.11,10538,(T2D) type 2 diabetes genetic risk >= 1.20,0.03,0.03,2
(T2D) type 2 diabetes genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.659,0.0,0.0,0.0,0.0091,0.0,0.02,0.3071,(T2D) type 2 diabetes genetic risk,1.11,10538,(T2D) type 2 diabetes genetic risk >= 1.20,0.03,0.03,2
Type 2 diabetes,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent","Diabetes Mellitus, Non-Insulin-Dependent. A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.",0,0.676,0.0,0.0,0.0,0.0082,0.6205,0.001,0.0008,Type 2 diabetes,1.44,937,Type 2 diabetes < -4.70,-0.0,-0.0,2
Type 2 diabetes,C0011854,"Diabetes Mellitus, Insulin-Dependent","Diabetes Mellitus, Insulin-Dependent. A chronic condition characterized by minimal or absent production of insulin by the pancreas.",0,0.694,0.0,0.0,0.0,0.0082,0.6205,0.001,0.0008,Type 2 diabetes,1.44,937,Type 2 diabetes < -4.70,-0.0,-0.0,2
(AMD) age-related macular degeneration genetic risk,C0017921,Glycogen storage disease type II,"Glycogen storage disease type II. An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle (MUSCLE, SKELETAL); HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy (CARDIOMYOPATHY, HYPERTROPHIC). The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4)",0,0.415,0.0,0.0,0.0,0.0082,0.1648,0.005,0.3066,(AMD) age-related macular degeneration genetic risk,1.09,6753,-1.20 <= (AMD) age-related macular degeneration genetic risk < -0.88,0.14,0.14,2
(AMD) age-related macular degeneration genetic risk,C0242383,Age related macular degeneration,"Age related macular degeneration. Age-related loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.",0,0.76,0.0,0.0,0.0,0.0082,0.1648,0.005,0.3066,(AMD) age-related macular degeneration genetic risk,1.09,6753,-1.20 <= (AMD) age-related macular degeneration genetic risk < -0.88,0.14,0.14,2
(AMD) age-related macular degeneration genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.541,0.0,0.0,0.0,0.0082,0.1648,0.005,0.3066,(AMD) age-related macular degeneration genetic risk,1.09,6753,-1.20 <= (AMD) age-related macular degeneration genetic risk < -0.88,0.14,0.14,2
Date of all cause dementia report,C0015127,Etiology aspects,Etiology aspects. Used with diseases for causative agents including microorganisms and includes environmental and social factors and personal habits as contributing factors. It includes pathogenesis.,0,0.161,0.0,0.0,0.0,0.0081,0.0,-0.023,0.0019,Date of all cause dementia report,1.0,91105,-5.20 <= Date of all cause dementia report < 1.10,-0.06,-0.06,99
Date of all cause dementia report,C0011265,Presenile dementia,Presenile dementia. The presence of dementia in an individual younger than age sixty five.,0,0.364,0.0,0.0,0.0,0.0081,0.0,-0.023,0.0019,Date of all cause dementia report,1.0,91105,-5.20 <= Date of all cause dementia report < 1.10,-0.06,-0.06,2
Date of all cause dementia report,C0497327,Dementia,"Dementia. An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.",0,0.442,0.0,0.0,0.0,0.0081,0.0,-0.023,0.0019,Date of all cause dementia report,1.0,91105,-5.20 <= Date of all cause dementia report < 1.10,-0.06,-0.06,2
Congestive heart failure (CHF) NOS,C0018802,Congestive heart failure,"Congestive heart failure. Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.",0,0.712,0.0,0.0,0.0,0.0074,0.07,0.007,0.0016,Congestive heart failure (CHF) NOS,0.98,90159,-0.20 <= Congestive heart failure (CHF) NOS < 0.76,0.07,0.07,2
"N18.3 - Chronic kidney disease, stage",C1561643,Chronic Kidney Diseases,Chronic Kidney Diseases. Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.,0,0.568,0.0,0.0,0.0,0.0073,0.1787,0.012,0.0011,"N18.3 - Chronic kidney disease, stage 3",0.98,90180,"-0.83 <= N18.3 - Chronic kidney disease, stage 3 < 1.20",0.16,0.16,2
Mental health conditions ever diagnosed by a professional group group,C0687744,Social group,"Social group. A collection of two or more people who share a common identity as defined by beliefs, codes of conduct, CULTURE and SOCIAL NORMS.",0,0.226,0.0,0.0,0.0,0.0062,0.0,-0.036,0.001,Mental health conditions ever diagnosed by a professional__group group,1.06,68835,Mental health conditions ever diagnosed by a professional__group group < 0.03,0.02,0.02,2
Acetone,C0001002,acetone,acetone. A colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during ketoacidosis.,0,0.864,0.0,0.0,0.0,0.0062,0.0,0.024,0.0816,Acetone,1.36,2195,2.40 <= Acetone < 10.00,-0.1,-0.1,2
Townsend deprivation index at recruitment,C2949735,Recruitment,"Recruitment. The process of enrolling, enlisting, or adding individuals to a group.",0,0.144,0.0,0.0,0.0,0.0061,0.0,0.025,0.0094,Townsend deprivation index at recruitment,1.19,10276,1.40 <= Townsend deprivation index at recruitment < 2.90,-0.08,0.12,99
Total protein,C0555903,Total protein measurement,Total protein measurement. A quantitative measurement of the amount of total protein present in a sample.,0,0.881,0.0,0.0,0.0,0.0059,0.0,0.039,0.0165,Total protein,1.47,941,Total protein >= 2.70,-0.02,-0.02,2
Total protein,C1261360,Total protein result,Total protein result. ,0,0.923,0.0,0.0,0.0,0.0059,0.0,0.039,0.0165,Total protein,1.47,941,Total protein >= 2.70,-0.02,-0.02,99
"I48.9 - Atrial fibrillation and atrial flutter, unspecified",C0004238,Atrial Fibrillation,"Atrial Fibrillation. Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.",0,0.698,0.0,0.0,0.0,0.0057,0.4092,0.008,0.0004,"I48.9 - Atrial fibrillation and atrial flutter, unspecified",0.99,89925,"-2.70 <= I48.9 - Atrial fibrillation and atrial flutter, unspecified < 1.10",0.06,0.13,2
"I48.9 - Atrial fibrillation and atrial flutter, unspecified",C0344434,Atrial Fibrillation by ECG Finding,"Atrial Fibrillation by ECG Finding. An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. (CDISC)",0,0.69,0.0,0.0,0.0,0.0057,0.4092,0.008,0.0004,"I48.9 - Atrial fibrillation and atrial flutter, unspecified",0.99,89925,"-2.70 <= I48.9 - Atrial fibrillation and atrial flutter, unspecified < 1.10",0.06,0.13,99
"I48.9 - Atrial fibrillation and atrial flutter, unspecified",C0004239,Atrial Flutter,"Atrial Flutter. Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).",0,0.627,0.0,0.0,0.0,0.0057,0.4092,0.008,0.0004,"I48.9 - Atrial fibrillation and atrial flutter, unspecified",0.99,89925,"-2.70 <= I48.9 - Atrial fibrillation and atrial flutter, unspecified < 1.10",0.06,0.13,2
"I48.9 - Atrial fibrillation and atrial flutter, unspecified",C0344423,Atrial Flutter by ECG Finding,"Atrial Flutter by ECG Finding. An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate of 240-340 beats per minute. Multiple P waves typically appear in the inferior leads in a saw tooth like pattern between the QRS complexes. (CDISC)",0,0.667,0.0,0.0,0.0,0.0057,0.4092,0.008,0.0004,"I48.9 - Atrial fibrillation and atrial flutter, unspecified",0.99,89925,"-2.70 <= I48.9 - Atrial fibrillation and atrial flutter, unspecified < 1.10",0.06,0.13,99
"Other chronic ischemic heart disease, unspecified",C0264694,Chronic myocardial ischemia,Chronic myocardial ischemia. ,0,0.903,0.0,0.0,0.0,0.0056,0.2562,0.012,0.0017,"Other chronic ischemic heart disease, unspecified",1.57,3125,"Other chronic ischemic heart disease, unspecified >= 1.30",0.18,0.18,2
Abdominal pain,C0000737,Abdominal Pain,"Abdominal Pain. Sensation of discomfort, distress, or agony in the abdominal region.",0,0.909,0.0,0.0,0.0,0.005,0.7678,0.0,0.0006,Abdominal pain,1.2,3232,0.06 <= Abdominal pain < 2.80,0.01,0.01,2
Meat substitutes - vegetarian,C0042441,Vegetarian (finding,"Vegetarian (finding. A person who eats no meat; some may eat fish, eggs, or dairy products.",0,0.727,0.0,0.0,0.0,0.0048,0.255,0.004,0.0001,Meat substitutes - vegetarian,1.01,80042,-0.18 <= Meat substitutes - vegetarian < 3.10,0.01,0.16,2
Diverticulosis,C1510475,Diverticulosis,"Diverticulosis. A finding indicating the presence of multiple pouches, usually in the colonic or gastric wall.",0,0.798,0.0,0.0,0.0,0.0047,0.7367,0.002,0.0007,Diverticulosis,1.38,1508,-1.40 <= Diverticulosis < -0.09,0.19,0.19,2
Diverticulosis,C0810029,Diverticulosis and Diverticulitis,"Diverticulosis and Diverticulitis. <p>Diverticula are small pouches that bulge outward through the colon, or large intestine. If you have these pouches, you have a condition called diverticulosis. It becomes more common as people age. About half of all people over age 60 have it. Doctors believe the main cause is a low-fiber diet.</p> <p>Most people with diverticulosis don't have symptoms. Sometimes it causes mild cramps, bloating or constipation. Diverticulosis is often found through tests ordered for something else. For example, it is often found during a colonoscopy to screen for cancer. A high-fiber diet and mild pain reliever will often relieve symptoms.</p> <p>If the pouches become inflamed or infected, you have a condition called diverticulitis. The most common symptom is abdominal pain, usually on the left side. You may also have fever, nausea, vomiting, chills, cramping, and constipation. In serious cases, diverticulitis can lead to bleeding, tears, or blockages. Your doctor will do a physical exam and imaging tests to diagnose it. Treatment may include antibiotics, pain relievers, and a liquid diet. A serious case may require a hospital stay or surgery.</p> <p class="""">NIH: National Institute of Diabetes and Digestive and Kidney Diseases</p>",0,0.834,0.0,0.0,0.0,0.0047,0.7367,0.002,0.0007,Diverticulosis,1.38,1508,-1.40 <= Diverticulosis < -0.09,0.19,0.19,99
(VTE) venous thromboembolic disease genetic risk,C1997614,Thromboembolism of vein,Thromboembolism of vein. ,0,0.361,0.0,0.0,0.0,0.0045,0.7621,0.001,0.3077,(VTE) venous thromboembolic disease genetic risk,1.0,91418,(VTE) venous thromboembolic disease genetic risk < 3.60,0.1,0.1,2
(VTE) venous thromboembolic disease genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.708,0.0,0.0,0.0,0.0045,0.7621,0.001,0.3077,(VTE) venous thromboembolic disease genetic risk,1.0,91418,(VTE) venous thromboembolic disease genetic risk < 3.60,0.1,0.1,2
3-Hydroxybutyrate,C0106006,3-Hydroxybutyrate,3-Hydroxybutyrate. A hydroxy fatty acid anion and ketone body synthesized in the liver from acetyl-Coenzyme A (acetyl-CoA) by the enzyme 3-hydroxybutyrate dehydrogenase. 3-hydroxybutyrate can be used as an energy source when glucose levels drop. Elevated urine and serum levels of 3-hydroxybutyrate are seen in ketosis and ketoacidosis.,0,0.767,0.0,0.0,0.0,0.0044,0.0,0.023,0.1431,3-Hydroxybutyrate,1.11,14658,-0.49 <= 3-Hydroxybutyrate < -0.02,-0.1,-0.1,2
Other ill-defined and unknown causes of morbidity and mortality,C0026538,Morbidity - disease rate,Morbidity - disease rate. The proportion of patients with a particular disease during a given year per given unit of population.,0,0.255,0.0,0.0,0.0,0.0043,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.07,0.07,2
Other ill-defined and unknown causes of morbidity and mortality,C5669240,Morbidity Rate,"Morbidity Rate. A measure of the frequency of occurrence of a specific disease, injury, or disability in a defined population during a specified interval. [After Principles of Epidemiology in Public Health Practice, Third Edition. An Introduction to Applied Epidemiology and Biostatistics]",0,0.254,0.0,0.0,0.0,0.0043,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.07,0.07,99
Other ill-defined and unknown causes of morbidity and mortality,C0026565,Mortality Vital Statistics,Mortality Vital Statistics. All deaths reported in a given population.,0,0.406,0.0,0.0,0.0,0.0043,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.07,0.07,2
Other ill-defined and unknown causes of morbidity and mortality,C0026566,Aspects of mortality statistics,"Aspects of mortality statistics. Used with human and veterinary diseases for mortality statistics. For deaths resulting from various procedures statistically but for a death resulting in a specific case, use FATAL OUTCOME, not /mortality.",0,0.358,0.0,0.0,0.0,0.0043,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.07,0.07,99
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0178587,density,density. The amount of something per unit size.,0,0.247,0.0,0.0,0.0,0.0041,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.05,0.08,2
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.269,0.0,0.0,0.0,0.0041,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.05,0.08,4
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.268,0.0,0.0,0.0,0.0041,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.05,0.08,99
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0557750,Towns,Towns. Human settlements larger than a village but smaller than a city.,0,0.444,0.0,0.0,0.0,0.0041,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.05,0.08,99
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0439092,Less Than,Less Than. A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.,0,0.268,0.0,0.0,0.0,0.0041,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.05,0.08,99
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0547044,Smaller,"Smaller. Of lower rank, degree, or importance; of reduced size, extent, or degree; more limited in quantity.",0,0.311,0.0,0.0,0.0,0.0041,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.05,0.08,99
Home area population density - urban or rural England/Wales - Urban - less sparse,C0178587,density,density. The amount of something per unit size.,0,0.229,0.0,0.0,0.0,0.004,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.05,0.06,2
Home area population density - urban or rural England/Wales - Urban - less sparse,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.328,0.0,0.0,0.0,0.004,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.05,0.06,4
Home area population density - urban or rural England/Wales - Urban - less sparse,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.283,0.0,0.0,0.0,0.004,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.05,0.06,99
Home area population density - urban or rural England/Wales - Urban - less sparse,C0439092,Less Than,Less Than. A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.,0,0.307,0.0,0.0,0.0,0.004,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.05,0.06,99
Home area population density - urban or rural England/Wales - Urban - less sparse,C0547044,Smaller,"Smaller. Of lower rank, degree, or importance; of reduced size, extent, or degree; more limited in quantity.",0,0.315,0.0,0.0,0.0,0.004,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.05,0.06,99
"M15.9 - Polyarthrosis, unspecified",C0702154,Polyarthropathy,Polyarthropathy. ,0,0.766,0.0,0.0,0.0,0.004,0.0127,0.01,0.0002,"M15.9 - Polyarthrosis, unspecified",0.99,90102,"-0.16 <= M15.9 - Polyarthrosis, unspecified < 0.86",0.1,0.1,2
Cholesterol in IDL,C0008377,cholesterol,"cholesterol. The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.",0,0.494,0.0,0.0,0.0,0.0038,0.0,-0.038,0.0679,Cholesterol in IDL,1.76,1026,-4.60 <= Cholesterol in IDL < -3.20,-0.05,-0.05,2
Cholesterol in IDL,C0008387,Cholesterol Esters,Cholesterol Esters. Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.,0,0.586,0.0,0.0,0.0,0.0038,0.0,-0.038,0.0679,Cholesterol in IDL,1.76,1026,-4.60 <= Cholesterol in IDL < -3.20,-0.05,-0.05,2
(AD) alzheimer's disease genetic risk,C0002395,Alzheimer's Disease,"Alzheimer's Disease. A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)",0,0.675,0.0,0.0,0.0,0.0038,0.2627,-0.003,0.3071,(AD) alzheimer's disease genetic risk,1.01,5427,(AD) alzheimer's disease genetic risk >= 1.80,-0.01,-0.01,2
(AD) alzheimer's disease genetic risk,C1863052,"ALZHEIMER DISEASE, FAMILIAL, 1","ALZHEIMER DISEASE, FAMILIAL, 1. Alzheimer's disease caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.",0,0.763,0.0,0.0,0.0,0.0038,0.2627,-0.003,0.3071,(AD) alzheimer's disease genetic risk,1.01,5427,(AD) alzheimer's disease genetic risk >= 1.80,-0.01,-0.01,99
(AD) alzheimer's disease genetic risk,C1843013,"Alzheimer disease, familial, type 3","Alzheimer disease, familial, type 3. Alzheimer's disease with an early onset (starts before the age of 65). It is caused by mutations in the PSEN1 gene.",0,0.664,0.0,0.0,0.0,0.0038,0.2627,-0.003,0.3071,(AD) alzheimer's disease genetic risk,1.01,5427,(AD) alzheimer's disease genetic risk >= 1.80,-0.01,-0.01,2
(AD) alzheimer's disease genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.622,0.0,0.0,0.0,0.0038,0.2627,-0.003,0.3071,(AD) alzheimer's disease genetic risk,1.01,5427,(AD) alzheimer's disease genetic risk >= 1.80,-0.01,-0.01,2
Asthma,C0004096,Asthma,"Asthma. A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).",0,0.508,0.0,0.0,0.0,0.0036,0.0356,-0.005,0.0003,Asthma,1.14,1677,-2.60 <= Asthma < -0.08,0.01,0.01,2
Apolipoprotein B,C0003593,Apolipoproteins B,"Apolipoproteins B. Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA.",0,0.794,0.0,0.0,0.0,0.0036,0.0,-0.038,0.1289,Apolipoprotein B,1.37,4622,Apolipoprotein B < -1.70,-0.07,-0.07,2
Apolipoprotein B,C1412471,APOB gene,APOB gene. This gene plays a role in lipid transport.,0,0.727,0.0,0.0,0.0,0.0036,0.0,-0.038,0.1289,Apolipoprotein B,1.37,4622,Apolipoprotein B < -1.70,-0.07,-0.07,2
Apolipoprotein B,C0003591,Apolipoproteins,Apolipoproteins. Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.,0,0.713,0.0,0.0,0.0,0.0036,0.0,-0.038,0.1289,Apolipoprotein B,1.37,4622,Apolipoprotein B < -1.70,-0.07,-0.07,2
Apolipoprotein B to Apolipoprotein A1 ratio,C0003593,Apolipoproteins B,"Apolipoproteins B. Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA.",0,0.692,0.0,0.0,0.0,0.0033,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,-0.12,-0.12,2
Apolipoprotein B to Apolipoprotein A1 ratio,C1412471,APOB gene,APOB gene. This gene plays a role in lipid transport.,0,0.641,0.0,0.0,0.0,0.0033,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,-0.12,-0.12,2
Apolipoprotein B to Apolipoprotein A1 ratio,C0003591,Apolipoproteins,Apolipoproteins. Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.,0,0.587,0.0,0.0,0.0,0.0033,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,-0.12,-0.12,2
Apolipoprotein B to Apolipoprotein A1 ratio,C0085201,Apolipoprotein A-I,"Apolipoprotein A-I. The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE.",0,0.632,0.0,0.0,0.0,0.0033,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,-0.12,-0.12,2
Apolipoprotein B to Apolipoprotein A1 ratio,C1412468,APOA1 gene,APOA1 gene. This gene is involved in cholesterol transport and metabolism.,0,0.595,0.0,0.0,0.0,0.0033,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,-0.12,-0.12,2
Apolipoprotein B to Apolipoprotein A1 ratio,C1677784,"APOA1 protein, human","APOA1 protein, human. Apolipoprotein A-I (267 aa, ~31 kDa) is encoded by the human APOA1 gene. This protein is involved in the transport and metabolism of cholesterol.",0,0.587,0.0,0.0,0.0,0.0033,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,-0.12,-0.12,99
Apolipoprotein B to Apolipoprotein A1 ratio,C0456603,Ratio,Ratio. Quotient of quantities of the same kind for different components within the same system.,0,0.271,0.0,0.0,0.0,0.0033,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,-0.12,-0.12,2
Acetoacetate,C0000988,Acetoacetates,Acetoacetates. Salts and derivatives of acetoacetic acid.,0,0.86,0.0,0.0,0.0,0.0032,0.0,0.034,0.1366,Acetoacetate,1.24,9070,Acetoacetate >= 0.62,-0.06,-0.06,2
Acetoacetate,C0220778,acetoacetate,acetoacetate. ,0,0.987,0.0,0.0,0.0,0.0032,0.0,0.034,0.1366,Acetoacetate,1.24,9070,Acetoacetate >= 0.62,-0.06,-0.06,2
Acetoacetate,C0392886,Acetoacetate measurement,Acetoacetate measurement. The determination of the amount of acetoacetic acid present in a sample.,0,0.665,0.0,0.0,0.0,0.0032,0.0,0.034,0.1366,Acetoacetate,1.24,9070,Acetoacetate >= 0.62,-0.06,-0.06,99
Concentration of Very Large VLDL Particles,C0023825,Very low density lipoprotein,"Very low density lipoprotein. A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues.",0,0.631,0.0,1.0,0.5,0.0032,0.0,0.029,0.0705,Concentration of Very Large VLDL Particles,1.4,2817,2.10 <= Concentration of Very Large VLDL Particles < 5.40,-0.06,-0.06,2
"dietary changes in the last 5 years Yes, because of other reasons",C0392747,Changing,Changing. The act of alteration or modification; changed or altered in form or character.,0,0.283,0.0,0.0,0.0,0.003,0.0065,-0.009,0.0,"Major dietary changes in the last 5 years_Yes, because of other reasons",1.02,67117,"Major dietary changes in the last 5 years_Yes, because of other reasons < 0.50",0.11,0.11,99
"dietary changes in the last 5 years Yes, because of other reasons",C0443172,Changed status,Changed status. ,0,0.271,0.0,0.0,0.0,0.003,0.0065,-0.009,0.0,"Major dietary changes in the last 5 years_Yes, because of other reasons",1.02,67117,"Major dietary changes in the last 5 years_Yes, because of other reasons < 0.50",0.11,0.11,99
Angina pectoris,C0002962,Angina Pectoris,"Angina Pectoris. The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.",0,0.784,0.0,0.0,0.0,0.0029,0.0441,-0.003,0.0011,Angina pectoris,1.54,1582,Angina pectoris < -3.20,0.18,0.18,2
Hypercholesterolemia,C0020443,Hypercholesterolemia,Hypercholesterolemia. A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.,0,0.897,0.0,0.0,0.0,0.0028,0.0,-0.008,0.0011,Hypercholesterolemia,1.58,2708,-5.60 <= Hypercholesterolemia < -2.00,-0.03,-0.03,2
Hypercholesterolemia,C1522133,Hypercholesterolemia result,Hypercholesterolemia result. A laboratory test result indicating an increased amount of cholesterol in the blood.,0,0.893,0.0,0.0,0.0,0.0028,0.0,-0.008,0.0011,Hypercholesterolemia,1.58,2708,-5.60 <= Hypercholesterolemia < -2.00,-0.03,-0.03,2
Sleep - Overall average,C0037313,Sleep,"Sleep. A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.",0,0.635,0.0,0.0,0.0,0.0027,0.5912,0.009,0.0357,Sleep - Overall average,1.02,80971,-0.12 <= Sleep - Overall average < 2.60,-0.0,-0.0,2
Sleep - Overall average,C0723362,Sleep brand of diphenhydramine hydrochloride,Sleep brand of diphenhydramine hydrochloride. ,0,0.35,0.0,0.0,0.0,0.0027,0.5912,0.009,0.0357,Sleep - Overall average,1.02,80971,-0.12 <= Sleep - Overall average < 2.60,-0.0,-0.0,99
Sleep - Overall average,C0037322,"Sleep, REM","Sleep, REM. A stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming.",0,0.542,0.0,0.0,0.0,0.0027,0.5912,0.009,0.0357,Sleep - Overall average,1.02,80971,-0.12 <= Sleep - Overall average < 2.60,-0.0,-0.0,2
Vascular/heart problems diagnosed by doctor High blood pressure,C0020538,Hypertensive disease,"Hypertensive disease. Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.",0,0.582,0.0,0.0,0.0,0.0027,0.0,0.082,0.0032,Vascular/heart problems diagnosed by doctor_High blood pressure,1.34,30845,Vascular/heart problems diagnosed by doctor_High blood pressure >= 0.50,0.02,0.02,2
Hemorrhage or hematoma complicating a procedure,C0019080,Hemorrhage,Hemorrhage. Bleeding or escape of blood from a vessel.,0,0.464,0.0,1.0,0.2,0.0025,0.0031,-0.004,0.0002,Hemorrhage or hematoma complicating a procedure,1.24,938,0.28 <= Hemorrhage or hematoma complicating a procedure < 9.30,0.06,0.06,2
Hemorrhage or hematoma complicating a procedure,C0029163,Oral Hemorrhage,"Oral Hemorrhage. Bleeding from the blood vessels of the mouth, which may occur as a result of injuries to the mouth, accidents in oral surgery, or diseases of the gums.",0,0.325,0.0,1.0,0.2,0.0025,0.0031,-0.004,0.0002,Hemorrhage or hematoma complicating a procedure,1.24,938,0.28 <= Hemorrhage or hematoma complicating a procedure < 9.30,0.06,0.06,2
Hemorrhage or hematoma complicating a procedure,C0426747,Bleeding from anus,Bleeding from anus. Bleeding originating from the anal area.,0,0.419,0.0,1.0,0.2,0.0025,0.0031,-0.004,0.0002,Hemorrhage or hematoma complicating a procedure,1.24,938,0.28 <= Hemorrhage or hematoma complicating a procedure < 9.30,0.06,0.06,2
Hemorrhage or hematoma complicating a procedure,C0018944,Hematoma,"Hematoma. A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.",0,0.568,0.0,1.0,0.2,0.0025,0.0031,-0.004,0.0002,Hemorrhage or hematoma complicating a procedure,1.24,938,0.28 <= Hemorrhage or hematoma complicating a procedure < 9.30,0.06,0.06,2
Hemorrhage or hematoma complicating a procedure,C1522701,Complicating,Complicating. Making more complex or intricate.,0,0.17,0.0,1.0,0.2,0.0025,0.0031,-0.004,0.0002,Hemorrhage or hematoma complicating a procedure,1.24,938,0.28 <= Hemorrhage or hematoma complicating a procedure < 9.30,0.06,0.06,99
Concentration of IDL Particles,C0086045,Mental concentration,"Mental concentration. The act or process of concentrating, focusing the attention and mental energy on a single object to the exclusion of others.",0,0.152,0.0,0.0,0.0,0.0025,0.0,-0.033,0.0604,Concentration of IDL Particles,1.43,2252,-3.80 <= Concentration of IDL Particles < -2.40,0.04,0.04,2
Other peripheral nerve disorders,C4721453,Peripheral Nervous System Diseases,"Peripheral Nervous System Diseases. Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.",0,0.86,0.0,0.0,0.0,0.0024,0.0387,0.008,0.0004,Other peripheral nerve disorders,1.11,1588,-11.00 <= Other peripheral nerve disorders < -0.25,-0.01,-0.01,2
Benign neoplasm of colon,C0086692,Benign Neoplasm,"Benign Neoplasm. A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.",0,0.469,0.0,0.0,0.0,0.0023,0.7802,0.003,0.0007,Benign neoplasm of colon,1.2,3282,-8.00 <= Benign neoplasm of colon < -0.15,0.24,0.24,2
Benign neoplasm of colon,C0347197,Benign neoplasm of oral cavity,"Benign neoplasm of oral cavity. A non-metastasizing neoplasm arising from the oral cavity. Representative examples include hemangioma, tongue lipoma, and buccal mucosa papilloma.",0,0.463,0.0,0.0,0.0,0.0023,0.7802,0.003,0.0007,Benign neoplasm of colon,1.2,3282,-8.00 <= Benign neoplasm of colon < -0.15,0.24,0.24,2
Benign neoplasm of colon,C0347276,Benign neoplasm of anus,Benign neoplasm of anus. A non-metastasizing neoplasm arising from the anus. Representative examples include squamous papilloma and papillary hidradenoma.,0,0.638,0.0,0.0,0.0,0.0023,0.7802,0.003,0.0007,Benign neoplasm of colon,1.2,3282,-8.00 <= Benign neoplasm of colon < -0.15,0.24,0.24,99
Benign neoplasm of colon,C0009368,Colon structure (body structure),Colon structure (body structure). The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON.,0,0.542,0.0,0.0,0.0,0.0023,0.7802,0.003,0.0007,Benign neoplasm of colon,1.2,3282,-8.00 <= Benign neoplasm of colon < -0.15,0.24,0.24,2
Benign neoplasm of colon,C2684091,"TUBE,COLON,22FR,RADIOPAQUE RUBBER B#7370","TUBE,COLON,22FR,RADIOPAQUE RUBBER B#7370. ",0,0.32,0.0,0.0,0.0,0.0023,0.7802,0.003,0.0007,Benign neoplasm of colon,1.2,3282,-8.00 <= Benign neoplasm of colon < -0.15,0.24,0.24,99
Cholesterol in Chylomicrons and Extremely Large VLDL,C0008377,cholesterol,"cholesterol. The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.",0,0.556,0.0,0.0,0.0,0.0022,0.0,0.028,0.0698,Cholesterol in Chylomicrons and Extremely Large VLDL,1.33,2792,2.00 <= Cholesterol in Chylomicrons and Extremely Large VLDL < 4.90,-0.05,-0.05,2
Cholesterol in Chylomicrons and Extremely Large VLDL,C0008387,Cholesterol Esters,Cholesterol Esters. Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.,0,0.585,0.0,0.0,0.0,0.0022,0.0,0.028,0.0698,Cholesterol in Chylomicrons and Extremely Large VLDL,1.33,2792,2.00 <= Cholesterol in Chylomicrons and Extremely Large VLDL < 4.90,-0.05,-0.05,2
Cholesterol in Chylomicrons and Extremely Large VLDL,C0008731,Chylomicrons,Chylomicrons. A class of lipoproteins that carry dietary CHOLESTEROL and TRIGLYCERIDES from the SMALL INTESTINE to the tissues. Their density (0.93-1.006 g/ml) is the same as that of VERY-LOW-DENSITY LIPOPROTEINS.,0,0.623,0.0,0.0,0.0,0.0022,0.0,0.028,0.0698,Cholesterol in Chylomicrons and Extremely Large VLDL,1.33,2792,2.00 <= Cholesterol in Chylomicrons and Extremely Large VLDL < 4.90,-0.05,-0.05,2
Cholesterol in Chylomicrons and Extremely Large VLDL,C1325761,chylomicron location,"chylomicron location. A large lipoprotein particle (diameter 75-1200 nm) composed of a central core of triglycerides and cholesterol surrounded by a protein-phospholipid coating. The proteins include one molecule of apolipoprotein B-48 and may include a variety of apolipoproteins, including APOAs, APOCs and APOE. Chylomicrons are found in blood or lymph and carry lipids from the intestines into other body tissues. [GOC:jl, GOC:rl, PMID:10580165]",0,0.56,0.0,0.0,0.0,0.0022,0.0,0.028,0.0698,Cholesterol in Chylomicrons and Extremely Large VLDL,1.33,2792,2.00 <= Cholesterol in Chylomicrons and Extremely Large VLDL < 4.90,-0.05,-0.05,99
Cholesterol in Chylomicrons and Extremely Large VLDL,C0023825,Very low density lipoprotein,"Very low density lipoprotein. A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues.",0,0.729,0.0,0.0,0.0,0.0022,0.0,0.028,0.0698,Cholesterol in Chylomicrons and Extremely Large VLDL,1.33,2792,2.00 <= Cholesterol in Chylomicrons and Extremely Large VLDL < 4.90,-0.05,-0.05,2
Cholesterol in Very Large HDL,C0008377,cholesterol,"cholesterol. The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.",0,0.593,0.0,0.0,0.0,0.0021,0.0,-0.043,0.0699,Cholesterol in Very Large HDL,1.97,1192,-4.10 <= Cholesterol in Very Large HDL < -2.50,-0.0,-0.0,2
Cholesterol in Very Large HDL,C0008387,Cholesterol Esters,Cholesterol Esters. Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.,0,0.549,0.0,0.0,0.0,0.0021,0.0,-0.043,0.0699,Cholesterol in Very Large HDL,1.97,1192,-4.10 <= Cholesterol in Very Large HDL < -2.50,-0.0,-0.0,2
Septicemia,C0036690,Septicemia,Septicemia. Systemic disease associated with the presence of pathogenic microorganisms or their toxins in the blood.,0,0.826,0.0,0.0,0.0,0.0021,0.0044,-0.008,0.0001,Septicemia,1.0,90187,-5.10 <= Septicemia < 0.10,-0.13,-0.13,2
Septicemia,C0243026,Sepsis,"Sepsis. Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.",0,0.707,0.0,0.0,0.0,0.0021,0.0044,-0.008,0.0001,Septicemia,1.0,90187,-5.10 <= Septicemia < 0.10,-0.13,-0.13,2
Acetate,C0000975,acetate,"acetate. Salt or ester form of acetic acid. Acetate is the most common building block for biosynthesis, such as fatty acids.",0,0.788,0.0,0.0,0.0,0.0021,0.0,-0.004,0.1028,Acetate,1.0,86320,Acetate < 0.15,-0.03,-0.03,2
Other tests,C0022885,Laboratory Procedures,"Laboratory Procedures. Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.",0,0.613,0.0,0.0,0.0,0.002,0.0115,-0.012,0.0004,Other tests,1.01,88080,-2.40 <= Other tests < 0.10,-0.03,-0.03,2
Other tests,C0683443,tests and testing,tests and testing. ,0,0.78,0.0,0.0,0.0,0.002,0.0115,-0.012,0.0004,Other tests,1.01,88080,-2.40 <= Other tests < 0.10,-0.03,-0.03,2
Other serious medical condition/disability diagnosed by doctor Yes - you will be asked about this later by an interviewer,C0021821,Interviewers,Interviewers. The person who manages an interview and asks the questions.,0,0.228,0.0,0.0,0.0,0.0019,0.0,0.057,0.0016,Other serious medical condition/disability diagnosed by doctor_Yes - you will be asked about this later by an interviewer,1.3,22954,Other serious medical condition/disability diagnosed by doctor_Yes - you will be asked about this later by an interviewer >= 0.50,-0.02,-0.02,2
Diaphragmatic hernia,C0019284,Diaphragmatic Hernia,Diaphragmatic Hernia. Protrusion of abdominal structures into the THORAX as a result of congenital or traumatic defects in the respiratory DIAPHRAGM.,0,0.889,0.0,0.0,0.0,0.0018,0.3485,0.002,0.0001,Diaphragmatic hernia,1.13,2977,-4.40 <= Diaphragmatic hernia < -0.05,0.21,0.26,2
Diaphragmatic hernia,C0235833,Congenital diaphragmatic hernia,Congenital diaphragmatic hernia. Diaphragmatic hernia that is present at birth.,0,0.825,0.0,0.0,0.0,0.0018,0.3485,0.002,0.0001,Diaphragmatic hernia,1.13,2977,-4.40 <= Diaphragmatic hernia < -0.05,0.21,0.26,2
Diaphragmatic hernia,C1840643,DIAPHRAGMATIC HERNIA 1,DIAPHRAGMATIC HERNIA 1. ,0,0.912,0.0,0.0,0.0,0.0018,0.3485,0.002,0.0001,Diaphragmatic hernia,1.13,2977,-4.40 <= Diaphragmatic hernia < -0.05,0.21,0.26,99
Coronary atherosclerosis,C0010054,Coronary Arteriosclerosis,"Coronary Arteriosclerosis. Thickening and loss of elasticity of the CORONARY ARTERIES, leading to progressive arterial insufficiency (CORONARY DISEASE).",0,0.834,0.0,0.0,0.0,0.0017,0.0124,-0.005,0.0014,Coronary atherosclerosis,1.55,2721,-4.90 <= Coronary atherosclerosis < -0.93,0.08,0.11,2
Other mental disorder,C0004936,Mental disorders,"Mental disorders. Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.",0,0.636,0.0,0.0,0.0,0.0017,0.3083,-0.0,0.0003,Other mental disorder,1.26,1240,-3.30 <= Other mental disorder < -2.20,-0.01,-0.01,2
Other mental disorder,C0033975,Psychotic Disorders,"Psychotic Disorders. Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)",0,0.491,0.0,0.0,0.0,0.0017,0.3083,-0.0,0.0003,Other mental disorder,1.26,1240,-3.30 <= Other mental disorder < -2.20,-0.01,-0.01,2
M79.66 - Pain in limb (Lower leg),C0030193,Pain,Pain. An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.,0,0.307,0.0,0.0,0.0,0.0016,0.1388,0.006,0.0002,M79.66 - Pain in limb (Lower leg),1.0,90618,-0.49 <= M79.66 - Pain in limb (Lower leg) < 0.39,0.06,0.06,2
M79.66 - Pain in limb (Lower leg),C1549543,Administration Method - Pain,Administration Method - Pain. ,0,0.194,0.0,0.0,0.0,0.0016,0.1388,0.006,0.0002,M79.66 - Pain in limb (Lower leg),1.0,90618,-0.49 <= M79.66 - Pain in limb (Lower leg) < 0.39,0.06,0.06,99
M79.66 - Pain in limb (Lower leg),C0015385,Limb structure,"Limb structure. The farthest or outermost projections of the body, such as the HAND and FOOT.",0,0.304,0.0,0.0,0.0,0.0016,0.1388,0.006,0.0002,M79.66 - Pain in limb (Lower leg),1.0,90618,-0.49 <= M79.66 - Pain in limb (Lower leg) < 0.39,0.06,0.06,2
M79.66 - Pain in limb (Lower leg),C1140621,Leg,Leg. The inferior part of the lower extremity between the KNEE and the ANKLE.,0,0.417,0.0,0.0,0.0,0.0016,0.1388,0.006,0.0002,M79.66 - Pain in limb (Lower leg),1.0,90618,-0.49 <= M79.66 - Pain in limb (Lower leg) < 0.39,0.06,0.06,2
M79.66 - Pain in limb (Lower leg),C4299093,Lower extremity>Lower leg,Lower extremity>Lower leg. ,0,0.414,0.0,0.0,0.0,0.0016,0.1388,0.006,0.0002,M79.66 - Pain in limb (Lower leg),1.0,90618,-0.49 <= M79.66 - Pain in limb (Lower leg) < 0.39,0.06,0.06,99
Alanine,C0001898,alanine,"alanine. A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.",0,0.775,0.0,0.0,0.0,0.0016,0.0,0.025,0.1066,Alanine,1.4,1058,Alanine >= 3.10,-0.15,-0.15,2
Z87.4 - Personal history of diseases of the genito-urinary system,C0262926,Medical History,"Medical History. A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.",0,0.242,0.0,0.0,0.0,0.0016,0.7627,0.003,0.0002,Z87.4 - Personal history of diseases of the genito-urinary system,0.99,89488,-2.00 <= Z87.4 - Personal history of diseases of the genito-urinary system < 0.02,0.02,0.02,2
Z87.4 - Personal history of diseases of the genito-urinary system,C0424945,Social and personal history,Social and personal history. ,0,0.173,0.0,0.0,0.0,0.0016,0.7627,0.003,0.0002,Z87.4 - Personal history of diseases of the genito-urinary system,0.99,89488,-2.00 <= Z87.4 - Personal history of diseases of the genito-urinary system < 0.02,0.02,0.02,99
Z87.4 - Personal history of diseases of the genito-urinary system,C0042066,Genitourinary system,"Genitourinary system. All the organs involved in reproduction and the formation and release of URINE. It includes the kidneys, ureters, BLADDER; URETHRA, and the organs of reproduction - ovaries, UTERUS; FALLOPIAN TUBES; VAGINA; and CLITORIS in women and the testes; SEMINAL VESICLES; PROSTATE; seminal ducts; and PENIS in men.",0,0.47,0.0,0.0,0.0,0.0016,0.7627,0.003,0.0002,Z87.4 - Personal history of diseases of the genito-urinary system,0.99,89488,-2.00 <= Z87.4 - Personal history of diseases of the genito-urinary system < 0.02,0.02,0.02,2
Circulatory disease NEC,C0135615,Proprotein Convertase 1,Proprotein Convertase 1. A CALCIUM-dependent endopeptidase that has specificity for cleavage at ARGININE that is near paired basic residues. It cleaves a variety of prohormones including PRO-OPIOMELANOCORTIN; PRORENIN; proenkephalins; prodynorphin; prosomatostatin; and PROINSULIN.,0,0.161,0.0,0.0,0.0,0.0015,0.039,-0.002,0.0007,Circulatory disease NEC,1.39,1979,-4.80 <= Circulatory disease NEC < -0.20,0.03,0.03,2
Alcoholism,C0001973,"Alcoholic Intoxication, Chronic","Alcoholic Intoxication, Chronic. A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)",0,0.654,0.0,0.0,0.0,0.0015,0.1093,0.006,0.0006,Alcoholism,0.99,88470,-0.25 <= Alcoholism < 0.09,-0.04,-0.04,2
M54.56 - Low back pain (Lumbar region),C0024031,Low Back Pain,"Low Back Pain. Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.",0,0.463,0.0,0.0,0.0,0.0015,0.0004,0.012,0.0002,M54.56 - Low back pain (Lumbar region),1.0,91086,-17.00 <= M54.56 - Low back pain (Lumbar region) < 0.75,0.01,0.01,2
M54.56 - Low back pain (Lumbar region),C0024090,Lumbar Region,Lumbar Region. The region of the spine below the ribs and above the hipbones.,0,0.515,0.0,0.0,0.0,0.0015,0.0004,0.012,0.0002,M54.56 - Low back pain (Lumbar region),1.0,91086,-17.00 <= M54.56 - Low back pain (Lumbar region) < 0.75,0.01,0.01,2
Enthesopathy,C0242490,Enthesopathy,Enthesopathy. A disorder occurring at the site of insertion of TENDONS or LIGAMENTS into bones or JOINT CAPSULES.,0,0.815,0.0,0.0,0.0,0.0015,0.2969,0.006,0.0003,Enthesopathy,0.99,89803,-3.50 <= Enthesopathy < 0.08,0.01,0.01,2
Cholesterol in Very Small VLDL,C0008377,cholesterol,"cholesterol. The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.",0,0.461,0.0,0.0,0.0,0.0014,0.0,-0.029,0.0525,Cholesterol in Very Small VLDL,1.29,6102,-4.60 <= Cholesterol in Very Small VLDL < -1.30,-0.11,-0.11,2
Cholesterol in Very Small VLDL,C0008387,Cholesterol Esters,Cholesterol Esters. Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.,0,0.532,0.0,0.0,0.0,0.0014,0.0,-0.029,0.0525,Cholesterol in Very Small VLDL,1.29,6102,-4.60 <= Cholesterol in Very Small VLDL < -1.30,-0.11,-0.11,2
"Cellulitis and abscess of foot, toe",C0007642,Cellulitis,"Cellulitis. An acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection of a wound, ulcer, or other skin lesions.",0,0.653,0.0,0.0,0.0,0.0014,0.1636,0.006,0.0006,"Cellulitis and abscess of foot, toe",1.7,969,"2.30 <= Cellulitis and abscess of foot, toe < 7.60",-0.2,-0.2,2
"Cellulitis and abscess of foot, toe",C0000833,Abscess,"Abscess. Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.",0,0.577,0.0,0.0,0.0,0.0014,0.1636,0.006,0.0006,"Cellulitis and abscess of foot, toe",1.7,969,"2.30 <= Cellulitis and abscess of foot, toe < 7.60",-0.2,-0.2,2
"Qualifications A levels/AS levels or equivalent|O levels/GCSEs or equivalent|Other professional qualifications eg: nursing, teaching",C0028677,Discipline of Nursing,"Discipline of Nursing. The field of nursing care concerned with the promotion, maintenance, and restoration of health.",0,0.319,0.0,0.0,0.0,0.0014,0.0004,-0.012,0.0001,"Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|Other professional qualifications eg: nursing, teaching",1.0,90185,"Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|Other professional qualifications eg: nursing, teaching < 0.50",-0.08,-0.08,3
"Qualifications A levels/AS levels or equivalent|O levels/GCSEs or equivalent|Other professional qualifications eg: nursing, teaching",C0028678,nursing therapy,"nursing therapy. Used with diseases for nursing care and techniques in their management. It includes the nursing role in diagnostic, therapeutic, and preventive procedures.",0,0.197,0.0,0.0,0.0,0.0014,0.0004,-0.012,0.0001,"Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|Other professional qualifications eg: nursing, teaching",1.0,90185,"Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|Other professional qualifications eg: nursing, teaching < 0.50",-0.08,-0.08,2
Average Diameter for VLDL Particles,C1301886,Diameter (qualifier value),Diameter (qualifier value). The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.,0,0.421,0.0,0.0,0.0,0.0014,0.0,0.031,0.0285,Average Diameter for VLDL Particles,1.87,986,3.30 <= Average Diameter for VLDL Particles < 5.90,-0.02,-0.02,2
Gastritis and duodenitis,C0017152,Gastritis,"Gastritis. Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.",0,0.733,0.0,0.0,0.0,0.0014,0.2051,0.008,0.0004,Gastritis and duodenitis,1.27,2228,0.49 <= Gastritis and duodenitis < 4.60,0.19,0.19,2
Gastritis and duodenitis,C0013298,Duodenitis,"Duodenitis. Inflammation of the DUODENUM section of the small intestine (INTESTINE, SMALL). Erosive duodenitis may cause bleeding in the UPPER GI TRACT and PEPTIC ULCER.",0,0.746,0.0,0.0,0.0,0.0014,0.2051,0.008,0.0004,Gastritis and duodenitis,1.27,2228,0.49 <= Gastritis and duodenitis < 4.60,0.19,0.19,2
Gastritis and duodenitis,C1522057,Acute Enteritis of the Mouse Intestinal Tract,Acute Enteritis of the Mouse Intestinal Tract. ,0,0.499,0.0,0.0,0.0,0.0014,0.2051,0.008,0.0004,Gastritis and duodenitis,1.27,2228,0.49 <= Gastritis and duodenitis < 4.60,0.19,0.19,2
Overall health rating Excellent,C1548784,Excellent - Specimen Quality,Excellent - Specimen Quality. ,0,0.34,0.0,0.0,0.0,0.0012,0.0,-0.046,0.0012,Overall health rating_Excellent,1.05,81543,Overall health rating_Excellent < 0.50,-0.1,-0.1,99
Overall health rating Excellent,C1551022,Excellent - LanguageAbilityProficiency,Excellent - LanguageAbilityProficiency. ,0,0.216,0.0,0.0,0.0,0.0012,0.0,-0.046,0.0012,Overall health rating_Excellent,1.05,81543,Overall health rating_Excellent < 0.50,-0.1,-0.1,99
Overall health rating Excellent,C1961136,Excellent (qualifier value),Excellent (qualifier value). Conforming to the highest quality or standard.,0,0.509,0.0,0.0,0.0,0.0012,0.0,-0.046,0.0012,Overall health rating_Excellent,1.05,81543,Overall health rating_Excellent < 0.50,-0.1,-0.1,99
"M19.99 - Arthrosis, unspecified (Site unspecified)",C0022408,Arthropathy,Arthropathy. Diseases involving the JOINTS.,0,0.439,0.0,0.0,0.0,0.0012,0.7569,0.004,0.0003,"M19.99 - Arthrosis, unspecified (Site unspecified)",0.99,89932,"-0.86 <= M19.99 - Arthrosis, unspecified (Site unspecified) < 0.02",0.15,0.15,2
"M19.99 - Arthrosis, unspecified (Site unspecified)",C0029408,Degenerative polyarthritis,"Degenerative polyarthritis. A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.",0,0.281,0.0,0.0,0.0,0.0012,0.7569,0.004,0.0003,"M19.99 - Arthrosis, unspecified (Site unspecified)",0.99,89932,"-0.86 <= M19.99 - Arthrosis, unspecified (Site unspecified) < 0.02",0.15,0.15,2
"M19.99 - Arthrosis, unspecified (Site unspecified)",C4760573,Arthrosis,Arthrosis. ,0,0.52,0.0,0.0,0.0,0.0012,0.7569,0.004,0.0003,"M19.99 - Arthrosis, unspecified (Site unspecified)",0.99,89932,"-0.86 <= M19.99 - Arthrosis, unspecified (Site unspecified) < 0.02",0.15,0.15,99
"M19.99 - Arthrosis, unspecified (Site unspecified)",C0205370,Unspecified,Unspecified. Not stated explicitly or in detail.,0,0.261,0.0,0.0,0.0,0.0012,0.7569,0.004,0.0003,"M19.99 - Arthrosis, unspecified (Site unspecified)",0.99,89932,"-0.86 <= M19.99 - Arthrosis, unspecified (Site unspecified) < 0.02",0.15,0.15,99
"M19.99 - Arthrosis, unspecified (Site unspecified)",C1519812,Unspecified Anatomic Sites,Unspecified Anatomic Sites. Research that isn't focused on a specific site.,0,0.206,0.0,0.0,0.0,0.0012,0.7569,0.004,0.0003,"M19.99 - Arthrosis, unspecified (Site unspecified)",0.99,89932,"-0.86 <= M19.99 - Arthrosis, unspecified (Site unspecified) < 0.02",0.15,0.15,2
Shortness of breath,C0013404,Dyspnea,Dyspnea. Difficult or labored breathing.,0,0.865,0.0,0.0,0.0,0.0012,0.4974,0.007,0.0003,Shortness of breath,1.19,946,2.10 <= Shortness of breath < 7.40,-0.08,-0.08,2
Shortness of breath,C4054349,No Shortness of Breath,No Shortness of Breath. A response indicating that an individual has or had no shortness of breath.,0,0.563,0.0,0.0,0.0,0.0012,0.4974,0.007,0.0003,Shortness of breath,1.19,946,2.10 <= Shortness of breath < 7.40,-0.08,-0.08,99
M25.56 - Pain in joint (Lower leg),C0030193,Pain,Pain. An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.,0,0.213,0.0,0.0,0.0,0.0012,0.0548,0.008,0.0003,M25.56 - Pain in joint (Lower leg),0.99,90802,-0.65 <= M25.56 - Pain in joint (Lower leg) < 0.29,-0.01,-0.01,2
M25.56 - Pain in joint (Lower leg),C1549543,Administration Method - Pain,Administration Method - Pain. ,0,0.221,0.0,0.0,0.0,0.0012,0.0548,0.008,0.0003,M25.56 - Pain in joint (Lower leg),0.99,90802,-0.65 <= M25.56 - Pain in joint (Lower leg) < 0.29,-0.01,-0.01,99
M25.56 - Pain in joint (Lower leg),C1140621,Leg,Leg. The inferior part of the lower extremity between the KNEE and the ANKLE.,0,0.278,0.0,0.0,0.0,0.0012,0.0548,0.008,0.0003,M25.56 - Pain in joint (Lower leg),0.99,90802,-0.65 <= M25.56 - Pain in joint (Lower leg) < 0.29,-0.01,-0.01,2
M25.56 - Pain in joint (Lower leg),C4299093,Lower extremity>Lower leg,Lower extremity>Lower leg. ,0,0.308,0.0,0.0,0.0,0.0012,0.0548,0.008,0.0003,M25.56 - Pain in joint (Lower leg),0.99,90802,-0.65 <= M25.56 - Pain in joint (Lower leg) < 0.29,-0.01,-0.01,99
Tobacco use disorder,C0040336,Tobacco Use Disorder,Tobacco Use Disorder. Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.,0,0.878,0.0,0.0,0.0,0.0012,0.2196,-0.004,0.0003,Tobacco use disorder,1.25,1364,-6.60 <= Tobacco use disorder < -2.00,0.1,0.1,2
"Osteoarthrosis, localized, primary",C0029408,Degenerative polyarthritis,"Degenerative polyarthritis. A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.",0,0.66,0.0,0.0,0.0,0.0011,0.2175,-0.005,0.0006,"Osteoarthrosis, localized, primary",1.45,943,"-11.00 <= Osteoarthrosis, localized, primary < -2.90",0.03,0.03,2
"Osteoarthrosis, localized, primary",C3887876,OSTEOARTHRITIS SUSCEPTIBILITY 1,OSTEOARTHRITIS SUSCEPTIBILITY 1. ,0,0.586,0.0,0.0,0.0,0.0011,0.2175,-0.005,0.0006,"Osteoarthrosis, localized, primary",1.45,943,"-11.00 <= Osteoarthrosis, localized, primary < -2.90",0.03,0.03,99
"Osteoarthrosis, localized, primary",C0392752,Localized,Localized. Being confined or restricted to a particular location. [HPO:probinson],0,0.279,0.0,0.0,0.0,0.0011,0.2175,-0.005,0.0006,"Osteoarthrosis, localized, primary",1.45,943,"-11.00 <= Osteoarthrosis, localized, primary < -2.90",0.03,0.03,2
"Osteoarthrosis, localized, primary",C0205225,Primary,Primary. Occurring first in time or sequence; original; of greatest rank or importance or value.,0,0.228,0.0,0.0,0.0,0.0011,0.2175,-0.005,0.0006,"Osteoarthrosis, localized, primary",1.45,943,"-11.00 <= Osteoarthrosis, localized, primary < -2.90",0.03,0.03,99
M47.82 - Other spondylosis (Cervical region),C0556956,Cervical region (surface region of back),Cervical region (surface region of back). ,0,0.414,0.0,0.0,0.0,0.001,0.1002,-0.005,0.0002,M47.82 - Other spondylosis (Cervical region),1.0,90852,-0.73 <= M47.82 - Other spondylosis (Cervical region) < 0.34,0.14,0.19,99
M47.82 - Other spondylosis (Cervical region),C0920882,Region of neck (body structure),"Region of neck (body structure). subdivision of cardinal body part, each instance of which is a regional part of some neck. Examples: front of neck, back of neck, throat.",0,0.315,0.0,0.0,0.0,0.001,0.1002,-0.005,0.0002,M47.82 - Other spondylosis (Cervical region),1.0,90852,-0.73 <= M47.82 - Other spondylosis (Cervical region) < 0.34,0.14,0.19,2
Pneumococcal pneumonia,C0032300,Lobar Pneumonia,Lobar Pneumonia. ,0,0.591,0.0,0.0,0.0,0.001,0.1003,-0.004,0.0002,Pneumococcal pneumonia,1.0,90494,-4.70 <= Pneumococcal pneumonia < 5.00,-0.04,-0.04,2
Pneumococcal pneumonia,C0155862,Streptococcal pneumonia,Streptococcal pneumonia. A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.,0,0.793,0.0,0.0,0.0,0.001,0.1003,-0.004,0.0002,Pneumococcal pneumonia,1.0,90494,-4.70 <= Pneumococcal pneumonia < 5.00,-0.04,-0.04,2
Osteoarthritis; localized,C0029408,Degenerative polyarthritis,"Degenerative polyarthritis. A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.",0,0.621,0.0,0.0,0.0,0.001,0.018,-0.004,0.0002,Osteoarthritis; localized,1.12,947,-5.50 <= Osteoarthritis; localized < -0.13,-0.01,-0.01,2
Osteoarthritis; localized,C0949690,Spondylarthritis,"Spondylarthritis. Inflammation of the joints of the SPINE, the intervertebral articulations.",0,0.487,0.0,0.0,0.0,0.001,0.018,-0.004,0.0002,Osteoarthritis; localized,1.12,947,-5.50 <= Osteoarthritis; localized < -0.13,-0.01,-0.01,2
Osteoarthritis; localized,C2350242,"Osteoarthritis, Spine","Osteoarthritis, Spine. A degenerative joint disease involving the SPINE. It is characterized by progressive deterioration of the spinal articular cartilage (CARTILAGE, ARTICULAR), usually with hardening of the subchondral bone and outgrowth of bone spurs (OSTEOPHYTE).",0,0.494,0.0,0.0,0.0,0.001,0.018,-0.004,0.0002,Osteoarthritis; localized,1.12,947,-5.50 <= Osteoarthritis; localized < -0.13,-0.01,-0.01,99
Osteoarthritis; localized,C0392752,Localized,Localized. Being confined or restricted to a particular location. [HPO:probinson],0,0.415,0.0,0.0,0.0,0.001,0.018,-0.004,0.0002,Osteoarthritis; localized,1.12,947,-5.50 <= Osteoarthritis; localized < -0.13,-0.01,-0.01,2
Hyposmolality and/or hyponatremia,C0268005,Hyposmolality syndrome,Hyposmolality syndrome. ,0,0.907,0.0,0.0,0.0,0.001,0.6833,-0.002,0.0001,Hyposmolality and/or hyponatremia,1.0,90782,-0.35 <= Hyposmolality and/or hyponatremia < 1.20,-0.0,-0.0,2
Hyposmolality and/or hyponatremia,C0020625,Hyponatremia,"Hyponatremia. Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)",0,0.538,0.0,0.0,0.0,0.001,0.6833,-0.002,0.0001,Hyposmolality and/or hyponatremia,1.0,90782,-0.35 <= Hyposmolality and/or hyponatremia < 1.20,-0.0,-0.0,2
Rash and other nonspecific skin eruption,C0015230,Exanthema,"Exanthema. Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.",0,0.679,0.0,0.0,0.0,0.001,0.0733,-0.004,0.0002,Rash and other nonspecific skin eruption,1.0,90827,-1.00 <= Rash and other nonspecific skin eruption < 0.34,-0.09,-0.09,2
Rash and other nonspecific skin eruption,C0302295,Eruptions,Eruptions. ,0,0.697,0.0,0.0,0.0,0.001,0.0733,-0.004,0.0002,Rash and other nonspecific skin eruption,1.0,90827,-1.00 <= Rash and other nonspecific skin eruption < 0.34,-0.09,-0.09,2
Rash and other nonspecific skin eruption,C0521471,Systemic lupus erythematosus rash,Systemic lupus erythematosus rash. A rash associated with systemic lupus erythematosus.,0,0.583,0.0,0.0,0.0,0.001,0.0733,-0.004,0.0002,Rash and other nonspecific skin eruption,1.0,90827,-1.00 <= Rash and other nonspecific skin eruption < 0.34,-0.09,-0.09,99
Hearing loss,C0011053,Deafness,Deafness. A general term for the complete loss of the ability to hear from both ears.,0,0.792,0.0,0.0,0.0,0.001,0.4131,0.006,0.0003,Hearing loss,1.0,90120,-0.47 <= Hearing loss < 0.54,-0.07,-0.07,2
Hearing loss,C0018772,"Hearing Loss, Partial","Hearing Loss, Partial. A condition in which a person partially loses the ability to hear sounds in one or both ears.",0,0.797,0.0,0.0,0.0,0.001,0.4131,0.006,0.0003,Hearing loss,1.0,90120,-0.47 <= Hearing loss < 0.54,-0.07,-0.07,2
Hearing loss,C1384666,hearing impairment,"hearing impairment. Partial or complete loss of the ability to detect or understand sounds resulting from damage to the outer, middle, or inner ear structures. Causes include exposure to loud noise, ear infections, injuries to the ear, genetic, and congenital disorders.",0,0.74,0.0,0.0,0.0,0.001,0.4131,0.006,0.0003,Hearing loss,1.0,90120,-0.47 <= Hearing loss < 0.54,-0.07,-0.07,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0008377,cholesterol,"cholesterol. The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.",0,0.381,0.0,1.0,0.1,0.0009,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",-0.08,-0.08,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0008387,Cholesterol Esters,Cholesterol Esters. Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.,0,0.392,0.0,1.0,0.1,0.0009,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",-0.08,-0.08,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0005823,Blood Pressure,Blood Pressure. PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.,0,0.34,0.0,1.0,0.1,0.0009,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",-0.08,-0.08,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0005824,Blood pressure determination,Blood pressure determination. Techniques used for measuring BLOOD PRESSURE.,0,0.293,0.0,1.0,0.1,0.0009,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",-0.08,-0.08,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C1271104,Blood pressure finding,Blood pressure finding. A test result that reports the diastolic and systolic pressure of the blood.,0,0.295,0.0,1.0,0.1,0.0009,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",-0.08,-0.08,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0011847,Diabetes,Diabetes. ,0,0.284,0.0,1.0,0.1,0.0009,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",-0.08,-0.08,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0362046,Prediabetes syndrome,"Prediabetes syndrome. The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).",0,0.175,0.0,1.0,0.1,0.0009,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",-0.08,-0.08,2
Average Diameter for LDL Particles,C1301886,Diameter (qualifier value),Diameter (qualifier value). The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.,0,0.466,0.0,0.0,0.0,0.0009,0.0,-0.027,0.0039,Average Diameter for LDL Particles,1.21,7036,-5.50 <= Average Diameter for LDL Particles < -0.75,-0.06,-0.06,2
hypertension,C0020538,Hypertensive disease,"Hypertensive disease. Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.",0,0.698,0.0,0.0,0.0,0.0009,0.0,0.084,0.0034,"Non-cancer illness code, self-reported | Array 0__hypertension",1.36,29822,"Non-cancer illness code, self-reported | Array 0__hypertension >= 0.61",-0.04,-0.04,2
hypertension,C0235222,Diastolic hypertension,Diastolic hypertension. Hypertension characterized diastolic blood pressure greater than 90 mmHg on two occasions.,0,0.469,0.0,0.0,0.0,0.0009,0.0,0.084,0.0034,"Non-cancer illness code, self-reported | Array 0__hypertension",1.36,29822,"Non-cancer illness code, self-reported | Array 0__hypertension >= 0.61",-0.04,-0.04,2
hypertension,C1696708,Prehypertension,"Prehypertension. Blood pressure levels that are between normotension and hypertension. Individuals with prehypertension are at a higher risk for developing cardiovascular diseases. Generally, prehypertension is defined as SYSTOLIC PRESSURE of 131-139 mm Hg and/or DIASTOLIC PRESSURE of 81-89 when the optimal is 120/80 mm Hg. For diabetics and other metabolism diseases the prehypertension is around 110-129/70-79 mm Hg.",0,0.622,0.0,0.0,0.0,0.0009,0.0,0.084,0.0034,"Non-cancer illness code, self-reported | Array 0__hypertension",1.36,29822,"Non-cancer illness code, self-reported | Array 0__hypertension >= 0.61",-0.04,-0.04,2
Other and unspecified disc disorder,C0012619,disc disorder,disc disorder. ,0,0.96,0.0,0.0,0.0,0.0009,0.1101,0.006,0.0003,Other and unspecified disc disorder,1.0,90789,-7.00 <= Other and unspecified disc disorder < 3.60,-0.1,-0.1,2
Altered mental status,C0392747,Changing,Changing. The act of alteration or modification; changed or altered in form or character.,0,0.394,0.0,0.0,0.0,0.0008,0.1685,-0.005,0.0001,Altered mental status,1.0,90929,-13.00 <= Altered mental status < 2.40,-0.07,-0.07,99
Altered mental status,C0278060,Mental state,Mental state. ,0,0.651,0.0,0.0,0.0,0.0008,0.1685,-0.005,0.0001,Altered mental status,1.0,90929,-13.00 <= Altered mental status < 2.40,-0.07,-0.07,2
Concentration of Large LDL Particles,C0549177,Large,"Large. Of considerable or relatively great size, extent, or capacity.",0,0.272,0.0,0.0,0.0,0.0008,0.0,-0.024,0.0683,Concentration of Large LDL Particles,1.16,7437,-3.50 <= Concentration of Large LDL Particles < -0.85,-0.1,-0.1,2
Concentration of Large LDL Particles,C1416798,LARGE1 gene,LARGE1 gene. ,0,0.282,0.0,0.0,0.0,0.0008,0.0,-0.024,0.0683,Concentration of Large LDL Particles,1.16,7437,-3.50 <= Concentration of Large LDL Particles < -0.85,-0.1,-0.1,2
Z96.6 - Presence of orthopaedic joint implants,C3854307,Presence (property),Presence (property). ,0,0.242,0.0,0.0,0.0,0.0008,0.0006,-0.007,0.0003,Z96.6 - Presence of orthopaedic joint implants,1.33,1458,-6.30 <= Z96.6 - Presence of orthopaedic joint implants < -0.35,0.06,0.07,99
Z96.6 - Presence of orthopaedic joint implants,C0021102,Implants,Implants. A prosthesis placed permanently in tissue.,0,0.45,0.0,0.0,0.0,0.0008,0.0006,-0.007,0.0003,Z96.6 - Presence of orthopaedic joint implants,1.33,1458,-6.30 <= Z96.6 - Presence of orthopaedic joint implants < -0.35,0.06,0.07,2
Alcohol-related disorders,C0236664,Alcohol Related Disorders,Alcohol Related Disorders. Disorders related to or resulting from abuse or misuse of alcohol.,0,0.961,0.0,0.0,0.0,0.0008,0.0049,0.009,0.0007,Alcohol-related disorders,0.99,89420,-0.04 <= Alcohol-related disorders < 0.44,-0.03,-0.03,2
infarction,C0021308,Infarction,"Infarction. Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.",0,0.739,0.0,0.0,0.0,0.0008,0.0,0.044,0.0008,"Non-cancer illness code, self-reported | Array 0__infarction",1.57,4618,"Non-cancer illness code, self-reported | Array 0__infarction >= 0.19",0.06,0.08,2
asthma,C0004096,Asthma,"Asthma. A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).",0,0.508,0.0,0.0,0.0,0.0007,0.0,0.026,0.0003,"Non-cancer illness code, self-reported | Array 1__asthma",1.36,4004,"Non-cancer illness code, self-reported | Array 1__asthma >= 0.50",0.01,0.01,2
Dental caries,C0011334,Dental caries,"Dental caries. Localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation. If left unchecked, the cavity may penetrate the enamel and dentin and reach the pulp.",0,0.784,0.0,0.0,0.0,0.0007,0.0656,-0.004,0.0002,Dental caries,1.0,90780,-1.90 <= Dental caries < 3.40,-0.06,-0.06,2
kidney,C0022646,Kidney,Kidney. Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.,0,0.676,0.0,0.0,0.0,0.0007,0.0,0.025,0.0005,"Non-cancer illness code, self-reported | Array 1__kidney",0.99,90998,"Non-cancer illness code, self-reported | Array 1__kidney < 0.11",0.01,0.01,2
kidney,C0227665,Both kidneys,Both kidneys. ,0,0.657,0.0,0.0,0.0,0.0007,0.0,0.025,0.0005,"Non-cancer illness code, self-reported | Array 1__kidney",0.99,90998,"Non-cancer illness code, self-reported | Array 1__kidney < 0.11",0.01,0.01,2
kidney,C0203408,Echography of kidney,Echography of kidney. The use of ultrasound to image the kidney.,0,0.508,0.0,0.0,0.0,0.0007,0.0,0.025,0.0005,"Non-cancer illness code, self-reported | Array 1__kidney",0.99,90998,"Non-cancer illness code, self-reported | Array 1__kidney < 0.11",0.01,0.01,2
Peripheral enthesopathies and allied syndromes,C0457623,Peripheral enthesopathy,Peripheral enthesopathy. ,0,0.859,0.0,0.0,0.0,0.0006,0.1883,0.006,0.0004,Peripheral enthesopathies and allied syndromes,0.99,89222,-2.10 <= Peripheral enthesopathies and allied syndromes < 0.90,-0.02,-0.02,2
"Other diseases of respiratory system, NEC",C0029896,Otorhinolaryngologic Diseases,"Otorhinolaryngologic Diseases. Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.",0,0.353,0.0,0.0,0.0,0.0006,0.0058,-0.006,0.0003,"Other diseases of respiratory system, NEC",1.01,1693,"Other diseases of respiratory system, NEC >= 2.10",0.07,0.07,2
"Other diseases of respiratory system, NEC",C0035237,Respiratory System,"Respiratory System. The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.",0,0.437,0.0,0.0,0.0,0.0006,0.0058,-0.006,0.0003,"Other diseases of respiratory system, NEC",1.01,1693,"Other diseases of respiratory system, NEC >= 2.10",0.07,0.07,2
"Other diseases of respiratory system, NEC",C0282686,Respiratory System Agents,Respiratory System Agents. Drugs used for their effects on the respiratory system.,0,0.471,0.0,0.0,0.0,0.0006,0.0058,-0.006,0.0003,"Other diseases of respiratory system, NEC",1.01,1693,"Other diseases of respiratory system, NEC >= 2.10",0.07,0.07,2
"Other diseases of respiratory system, NEC",C3541375,RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS. ,0,0.446,0.0,0.0,0.0,0.0006,0.0058,-0.006,0.0003,"Other diseases of respiratory system, NEC",1.01,1693,"Other diseases of respiratory system, NEC >= 2.10",0.07,0.07,99
Epistaxis or throat hemorrhage,C0014591,Epistaxis,Epistaxis. Bleeding from the nose.,0,0.776,0.0,0.0,0.0,0.0006,0.0024,-0.005,0.0004,Epistaxis or throat hemorrhage,0.99,90943,-0.65 <= Epistaxis or throat hemorrhage < 8.90,0.13,0.13,2
Epistaxis or throat hemorrhage,C0576995,Pharyngeal Hemorrhage,Pharyngeal Hemorrhage. Bleeding originating from the pharynx.,0,0.673,0.0,0.0,0.0,0.0006,0.0024,-0.005,0.0004,Epistaxis or throat hemorrhage,0.99,90943,-0.65 <= Epistaxis or throat hemorrhage < 8.90,0.13,0.13,99
depression,C0011570,Mental Depression,Mental Depression. Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.,0,0.588,0.0,0.0,0.0,0.0006,0.0536,-0.006,0.0,"Non-cancer illness code, self-reported | Array 1__depression",1.0,90295,"Non-cancer illness code, self-reported | Array 1__depression < 0.12",-0.04,-0.04,2
depression,C0011581,Depressive disorder,Depressive disorder. An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.,0,0.678,0.0,0.0,0.0,0.0006,0.0536,-0.006,0.0,"Non-cancer illness code, self-reported | Array 1__depression",1.0,90295,"Non-cancer illness code, self-reported | Array 1__depression < 0.12",-0.04,-0.04,2
depression,C0344315,Depressed mood,"Depressed mood. An emotional state characterized by feelings of sadness, emptiness, and/or tearfulness.",0,0.753,0.0,0.0,0.0,0.0006,0.0536,-0.006,0.0,"Non-cancer illness code, self-reported | Array 1__depression",1.0,90295,"Non-cancer illness code, self-reported | Array 1__depression < 0.12",-0.04,-0.04,2
Ulcerative colitis,C0009324,Ulcerative Colitis,"Ulcerative Colitis. Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.",0,0.717,0.0,0.0,0.0,0.0006,0.1793,-0.005,0.0002,Ulcerative colitis,1.0,91152,Ulcerative colitis >= -0.18,0.17,0.17,2
Umbilical hernia,C0019322,Umbilical hernia,Umbilical hernia. Protrusion of the abdominal cavity contents through the abdominal wall at the umbilicus.,0,0.952,0.0,0.0,0.0,0.0006,0.0074,-0.005,0.0002,Umbilical hernia,1.0,89838,-1.20 <= Umbilical hernia < 0.56,-0.0,-0.0,2
Umbilical hernia,C1306503,Congenital exomphalos,"Congenital exomphalos. A HERNIA due to an imperfect closure or weakness of the umbilical ring. It appears as a skin-covered protrusion at the UMBILICUS during crying, coughing, or straining. The hernia generally consists of OMENTUM or SMALL INTESTINE. The vast majority of umbilical hernias are congenital but can be acquired due to severe abdominal distention.",0,0.846,0.0,0.0,0.0,0.0006,0.0074,-0.005,0.0002,Umbilical hernia,1.0,89838,-1.20 <= Umbilical hernia < 0.56,-0.0,-0.0,3
Mental health conditions ever diagnosed by a professional group depression,C0011570,Mental Depression,Mental Depression. Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.,0,0.415,0.0,0.0,0.0,0.0006,0.0,-0.015,0.001,Mental health conditions ever diagnosed by a professional__group depression,1.01,87484,Mental health conditions ever diagnosed by a professional__group depression < 0.15,0.03,0.03,2
Mental health conditions ever diagnosed by a professional group depression,C0011581,Depressive disorder,Depressive disorder. An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.,0,0.577,0.0,0.0,0.0,0.0006,0.0,-0.015,0.001,Mental health conditions ever diagnosed by a professional__group depression,1.01,87484,Mental health conditions ever diagnosed by a professional__group depression < 0.15,0.03,0.03,2
Mental health conditions ever diagnosed by a professional group depression,C0344315,Depressed mood,"Depressed mood. An emotional state characterized by feelings of sadness, emptiness, and/or tearfulness.",0,0.407,0.0,0.0,0.0,0.0006,0.0,-0.015,0.001,Mental health conditions ever diagnosed by a professional__group depression,1.01,87484,Mental health conditions ever diagnosed by a professional__group depression < 0.15,0.03,0.03,2
Overall health rating Fair,C1547189,Fair Language Proficiency,Fair Language Proficiency. ,0,0.398,0.0,0.0,0.0,0.0006,0.0,0.05,0.0012,Overall health rating_Fair,1.24,25623,Overall health rating_Fair >= 0.50,-0.1,-0.1,99
Overall health rating Fair,C1548785,Fair Specimen Quality,Fair Specimen Quality. ,0,0.395,0.0,0.0,0.0,0.0006,0.0,0.05,0.0012,Overall health rating_Fair,1.24,25623,Overall health rating_Fair >= 0.50,-0.1,-0.1,99
Overall health rating Fair,C2911689,Fair (qualifier),Fair (qualifier). Having no exceptional quality or ability.,0,0.526,0.0,0.0,0.0,0.0006,0.0,0.05,0.0012,Overall health rating_Fair,1.24,25623,Overall health rating_Fair >= 0.50,-0.1,-0.1,99
Average Diameter for HDL Particles,C1301886,Diameter (qualifier value),Diameter (qualifier value). The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.,0,0.455,0.0,0.0,0.0,0.0006,0.0,-0.021,0.03,Average Diameter for HDL Particles,1.15,7281,-3.00 <= Average Diameter for HDL Particles < -0.96,0.01,0.01,2
M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,C0024090,Lumbar Region,Lumbar Region. The region of the spine below the ribs and above the hipbones.,0,0.398,0.0,0.0,0.0,0.0005,0.0877,0.007,0.0002,M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,1.0,90946,-9.00 <= M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy < 4.40,-0.01,-0.01,2
M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,C0700594,Radiculopathy,"Radiculopathy. Disease involving a spinal nerve root (see SPINAL NERVE ROOTS) which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.",0,0.685,0.0,0.0,0.0,0.0005,0.0877,0.007,0.0002,M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,1.0,90946,-9.00 <= M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy < 4.40,-0.01,-0.01,2
medication ibuprofen,C0020740,ibuprofen,"ibuprofen. A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties",0,0.906,0.0,0.0,0.0,0.0005,0.0,-0.026,0.0004,Treatment/medication code | Array 0__ibuprofen,1.02,87653,Treatment/medication code | Array 0__ibuprofen < 0.57,-0.06,-0.06,2
Rheumatoid arthritis,C0003873,Rheumatoid Arthritis,"Rheumatoid Arthritis. A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.",0,0.826,0.0,0.0,0.0,0.0005,0.15,0.004,0.0002,Rheumatoid arthritis,1.0,90983,-3.10 <= Rheumatoid arthritis < 3.60,0.05,0.05,2
Rheumatoid arthritis,C0038013,Ankylosing spondylitis,"Ankylosing spondylitis. A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.",0,0.514,0.0,0.0,0.0,0.0005,0.15,0.004,0.0002,Rheumatoid arthritis,1.0,90983,-3.10 <= Rheumatoid arthritis < 3.60,0.05,0.05,2
"dietary changes in the last 5 years Yes, because of illness",C0392747,Changing,Changing. The act of alteration or modification; changed or altered in form or character.,0,0.297,0.0,0.0,0.0,0.0005,0.0,0.054,0.0013,"Major dietary changes in the last 5 years_Yes, because of illness",1.37,14262,"Major dietary changes in the last 5 years_Yes, because of illness >= 0.50",0.11,0.11,99
"dietary changes in the last 5 years Yes, because of illness",C0443172,Changed status,Changed status. ,0,0.271,0.0,0.0,0.0,0.0005,0.0,0.054,0.0013,"Major dietary changes in the last 5 years_Yes, because of illness",1.37,14262,"Major dietary changes in the last 5 years_Yes, because of illness >= 0.50",0.11,0.11,99
medication cialis 10mg,C0967376,Cialis,Cialis. ,0,0.588,0.0,0.0,0.0,0.0005,0.1024,0.005,0.0,Treatment/medication code | Array 0__cialis 10mg,1.0,91536,Treatment/medication code | Array 0__cialis 10mg < 0.28,-0.11,-0.11,2
osteoarthritis,C0029408,Degenerative polyarthritis,"Degenerative polyarthritis. A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.",0,0.784,0.0,0.0,0.0,0.0005,0.0005,0.012,0.0001,"Non-cancer illness code, self-reported | Array 1__osteoarthritis",1.2,2704,"Non-cancer illness code, self-reported | Array 1__osteoarthritis >= 0.50",-0.0,-0.0,2
osteoarthritis,C0949690,Spondylarthritis,"Spondylarthritis. Inflammation of the joints of the SPINE, the intervertebral articulations.",0,0.548,0.0,0.0,0.0,0.0005,0.0005,0.012,0.0001,"Non-cancer illness code, self-reported | Array 1__osteoarthritis",1.2,2704,"Non-cancer illness code, self-reported | Array 1__osteoarthritis >= 0.50",-0.0,-0.0,2
osteoarthritis,C2350242,"Osteoarthritis, Spine","Osteoarthritis, Spine. A degenerative joint disease involving the SPINE. It is characterized by progressive deterioration of the spinal articular cartilage (CARTILAGE, ARTICULAR), usually with hardening of the subchondral bone and outgrowth of bone spurs (OSTEOPHYTE).",0,0.576,0.0,0.0,0.0,0.0005,0.0005,0.012,0.0001,"Non-cancer illness code, self-reported | Array 1__osteoarthritis",1.2,2704,"Non-cancer illness code, self-reported | Array 1__osteoarthritis >= 0.50",-0.0,-0.0,99
Syncope and collapse,C0039070,Syncope,"Syncope. A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)",0,0.682,0.0,0.0,0.0,0.0005,0.0264,-0.003,0.0003,Syncope and collapse,1.37,988,-5.90 <= Syncope and collapse < -0.17,-0.02,-0.02,2
Syncope and collapse,C3541349,Syncope (amphibian),Syncope (amphibian). ,0,0.662,0.0,0.0,0.0,0.0005,0.0264,-0.003,0.0003,Syncope and collapse,1.37,988,-5.90 <= Syncope and collapse < -0.17,-0.02,-0.02,99
Syncope and collapse,C0036974,Shock,Shock. A pathological condition manifested by failure to perfuse or oxygenate vital organs.,0,0.411,0.0,0.0,0.0,0.0005,0.0264,-0.003,0.0003,Syncope and collapse,1.37,988,-5.90 <= Syncope and collapse < -0.17,-0.02,-0.02,2
Syncope and collapse,C0332521,Collapse (morphologic abnormality),Collapse (morphologic abnormality). ,0,0.403,0.0,0.0,0.0,0.0005,0.0264,-0.003,0.0003,Syncope and collapse,1.37,988,-5.90 <= Syncope and collapse < -0.17,-0.02,-0.02,99
Syncope and collapse,C0344329,Collapse (finding),Collapse (finding). Failure of a physiologic function or system.,0,0.654,0.0,0.0,0.0,0.0005,0.0264,-0.003,0.0003,Syncope and collapse,1.37,988,-5.90 <= Syncope and collapse < -0.17,-0.02,-0.02,2
Qualifications NVQ or HND or HNC or equivalent,C0205163,Equal,Equal. A person or thing equal to another in value or measure or force or effect or significance etc.; being essentially equal to something.,0,0.229,0.0,0.0,0.0,0.0004,0.0026,0.01,0.0,Qualifications_NVQ or HND or HNC or equivalent,1.1,7423,Qualifications_NVQ or HND or HNC or equivalent >= 0.50,-0.02,-0.02,99
Other specified cardiac dysrhythmias,C0003811,Cardiac Arrhythmia,"Cardiac Arrhythmia. Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.",0,0.768,0.0,0.0,0.0,0.0004,0.1626,0.006,0.0003,Other specified cardiac dysrhythmias,0.99,90042,-0.12 <= Other specified cardiac dysrhythmias < 0.98,0.08,0.11,2
Other specified cardiac dysrhythmias,C0264886,Conduction disorder of the heart,Conduction disorder of the heart. A disorder affecting the conduction system that sends electrical signals in the myocardium.,0,0.718,0.0,0.0,0.0,0.0004,0.1626,0.006,0.0003,Other specified cardiac dysrhythmias,0.99,90042,-0.12 <= Other specified cardiac dysrhythmias < 0.98,0.08,0.11,2
Qualifications A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,C0018609,Hartnup Disease,"Hartnup Disease. An autosomal recessive disorder due to defective absorption of NEUTRAL AMINO ACIDS by both the intestine and the PROXIMAL RENAL TUBULES. The abnormal urinary loss of TRYPTOPHAN, a precursor of NIACIN, leads to a NICOTINAMIDE deficiency, PELLAGRA-like light-sensitive rash, CEREBELLAR ATAXIA, emotional instability, and aminoaciduria. Mutations involve the neurotransmitter transporter gene SLC6A19.",0,0.158,0.0,0.0,0.0,0.0004,0.0109,-0.008,0.0,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,1.0,90738,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent < 0.50,-0.01,-0.01,2
Qualifications A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,C5551064,SLC6A19 wt Allele,"SLC6A19 wt Allele. Human SLC6A19 wild-type allele is located in the vicinity of 5p15.33 and is approximately 24 kb in length. This allele, which encodes sodium-dependent neutral amino acid transporter B(0)AT1 protein, plays a role in epithelial cell uptake of neutral amino acids. Mutation of the gene is associated with iminoglycinuria, hyperglycinuria and Hartnup disorder.",0,0.174,0.0,0.0,0.0,0.0004,0.0109,-0.008,0.0,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,1.0,90738,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent < 0.50,-0.01,-0.01,99
Qualifications A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,C0205163,Equal,Equal. A person or thing equal to another in value or measure or force or effect or significance etc.; being essentially equal to something.,0,0.278,0.0,0.0,0.0,0.0004,0.0109,-0.008,0.0,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,1.0,90738,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent < 0.50,-0.01,-0.01,99
Qualifications A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,C0439185,Equivalent Weight,"Equivalent Weight. A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.",0,0.284,0.0,0.0,0.0,0.0004,0.0109,-0.008,0.0,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,1.0,90738,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent < 0.50,-0.01,-0.01,2
failure,C0231174,Failure (biologic function),Failure (biologic function). ,0,0.826,0.0,0.0,0.0,0.0004,0.0,0.035,0.0004,"Non-cancer illness code, self-reported | Array 2__failure",1.0,91470,"Non-cancer illness code, self-reported | Array 2__failure < 0.18",-0.04,-0.04,99
failure,C0680095,Personal failure,Personal failure. ,0,0.59,0.0,0.0,0.0,0.0004,0.0,0.035,0.0004,"Non-cancer illness code, self-reported | Array 2__failure",1.0,91470,"Non-cancer illness code, self-reported | Array 2__failure < 0.18",-0.04,-0.04,99
medication 100mg capsule,C0006935,capsule (pharmacologic),capsule (pharmacologic). Hard or soft soluble containers used for the oral administration of medicine.,0,0.294,0.0,0.0,0.0,0.0004,0.004,0.009,0.0,Treatment/medication code | Array 0__100mg capsule,1.0,91540,Treatment/medication code | Array 0__100mg capsule < 0.25,-0.0,-0.0,2
Qualifications College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,C0205163,Equal,Equal. A person or thing equal to another in value or measure or force or effect or significance etc.; being essentially equal to something.,0,0.305,0.0,0.0,0.0,0.0004,0.0001,-0.013,0.0001,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,1.01,88450,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent < 0.50,-0.02,0.0,99
Qualifications College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,C0439185,Equivalent Weight,"Equivalent Weight. A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.",0,0.279,0.0,0.0,0.0,0.0004,0.0001,-0.013,0.0001,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,1.01,88450,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent < 0.50,-0.02,0.0,2
Type 1 diabetes,C0011854,"Diabetes Mellitus, Insulin-Dependent","Diabetes Mellitus, Insulin-Dependent. A chronic condition characterized by minimal or absent production of insulin by the pancreas.",0,0.657,0.0,0.0,0.0,0.0004,0.0031,0.006,0.0002,Type 1 diabetes,1.0,90689,-0.06 <= Type 1 diabetes < 6.30,-0.02,-0.02,2
Type 1 diabetes,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent","Diabetes Mellitus, Non-Insulin-Dependent. A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.",0,0.674,0.0,0.0,0.0,0.0004,0.0031,0.006,0.0002,Type 1 diabetes,1.0,90689,-0.06 <= Type 1 diabetes < 6.30,-0.02,-0.02,2
Occlusion of cerebral arteries,C0001168,Complete obstruction,Complete obstruction. ,0,0.316,0.0,0.0,0.0,0.0004,0.0176,-0.005,0.0002,Occlusion of cerebral arteries,1.0,90341,-2.60 <= Occlusion of cerebral arteries < 0.04,-0.02,-0.02,2
Occlusion of cerebral arteries,C0011382,Dental Occlusion,"Dental Occlusion. The relationship of all the components of the masticatory system in normal function. It has special reference to the position and contact of the maxillary and mandibular teeth for the highest efficiency during the excursive movements of the jaw that are essential for mastication. (From Jablonski, Dictionary of Dentistry, 1992, p556, p472)",0,0.201,0.0,0.0,0.0,0.0004,0.0176,-0.005,0.0002,Occlusion of cerebral arteries,1.0,90341,-2.60 <= Occlusion of cerebral arteries < 0.04,-0.02,-0.02,2
Occlusion of cerebral arteries,C0028778,Obstruction,Obstruction. Blockage of the normal flow of the contents of an anatomical passageway.,0,0.254,0.0,0.0,0.0,0.0004,0.0176,-0.005,0.0002,Occlusion of cerebral arteries,1.0,90341,-2.60 <= Occlusion of cerebral arteries < 0.04,-0.02,-0.02,2
Occlusion of cerebral arteries,C0007770,Structure of cerebral artery,Structure of cerebral artery. The arterial blood vessels supplying the CEREBRUM.,0,0.751,0.0,0.0,0.0,0.0004,0.0176,-0.005,0.0002,Occlusion of cerebral arteries,1.0,90341,-2.60 <= Occlusion of cerebral arteries < 0.04,-0.02,-0.02,2
Occlusion of cerebral arteries,C4266573,Head>Cerebral arteries,Head>Cerebral arteries. ,0,0.743,0.0,0.0,0.0,0.0004,0.0176,-0.005,0.0002,Occlusion of cerebral arteries,1.0,90341,-2.60 <= Occlusion of cerebral arteries < 0.04,-0.02,-0.02,2
Congenital anomalies of great vessels,C0000768,Congenital Abnormality,Congenital Abnormality. Malformations of organs or body parts during development in utero.,0,0.48,0.0,0.0,0.0,0.0004,0.1697,0.005,0.0002,Congenital anomalies of great vessels,1.0,90650,-2.30 <= Congenital anomalies of great vessels < 0.41,0.1,0.1,2
Congenital anomalies of great vessels,C0266292,Congenital anomaly of the kidney,Congenital anomaly of the kidney. An abnormality of the kidney. [HPO:probinson],0,0.329,0.0,0.0,0.0,0.0004,0.1697,0.005,0.0002,Congenital anomalies of great vessels,1.0,90650,-2.30 <= Congenital anomalies of great vessels < 0.41,0.1,0.1,2
Congenital anomalies of great vessels,C0225991,Structure of great blood vessel (organ),"Structure of great blood vessel (organ). Any of the major arteries or veins attached to the cardiac atria or ventricles. This includes the aorta, superior and inferior vena cava and the pulmonary arteries and veins.",0,0.658,0.0,0.0,0.0,0.0004,0.1697,0.005,0.0002,Congenital anomalies of great vessels,1.0,90650,-2.30 <= Congenital anomalies of great vessels < 0.41,0.1,0.1,2
high cholesterol,C0020443,Hypercholesterolemia,Hypercholesterolemia. A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.,0,0.903,0.0,0.0,0.0,0.0004,0.007,0.009,0.0,"Non-cancer illness code, self-reported | Array 1__high cholesterol",1.1,5775,"Non-cancer illness code, self-reported | Array 1__high cholesterol >= 0.29",0.02,0.02,2
high cholesterol,C1522133,Hypercholesterolemia result,Hypercholesterolemia result. A laboratory test result indicating an increased amount of cholesterol in the blood.,0,0.887,0.0,0.0,0.0,0.0004,0.007,0.009,0.0,"Non-cancer illness code, self-reported | Array 1__high cholesterol",1.1,5775,"Non-cancer illness code, self-reported | Array 1__high cholesterol >= 0.29",0.02,0.02,2
Cholesterol in Large HDL,C0008377,cholesterol,"cholesterol. The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.",0,0.656,0.0,0.0,0.0,0.0004,0.0,-0.031,0.0636,Cholesterol in Large HDL,1.21,8276,-2.80 <= Cholesterol in Large HDL < -0.90,-0.02,-0.02,2
Cholesterol in Large HDL,C0008387,Cholesterol Esters,Cholesterol Esters. Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.,0,0.598,0.0,0.0,0.0,0.0004,0.0,-0.031,0.0636,Cholesterol in Large HDL,1.21,8276,-2.80 <= Cholesterol in Large HDL < -0.90,-0.02,-0.02,2
hypothyroidism,C0020676,Hypothyroidism,"Hypothyroidism. A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.",0,0.731,0.0,0.0,0.0,0.0004,0.1248,-0.005,0.0,"Non-cancer illness code, self-reported | Array 1__hypothyroidism",1.0,90531,"Non-cancer illness code, self-reported | Array 1__hypothyroidism < 0.29",0.12,0.12,2
hypothyroidism,C3665349,Secondary hypothyroidism,"Secondary hypothyroidism. Hypothyroidism due to dysfunction of the pituitary gland, which results in inadequate secretion of thyroid-stimulating hormone (thyrotropin).",0,0.793,0.0,0.0,0.0,0.0004,0.1248,-0.005,0.0,"Non-cancer illness code, self-reported | Array 1__hypothyroidism",1.0,90531,"Non-cancer illness code, self-reported | Array 1__hypothyroidism < 0.29",0.12,0.12,99
hypothyroidism,C0271801,Central hypothyroidism,Central hypothyroidism. Abnormally low levels of thyroid hormones due to a disorder originating within the hypothalamic-pituitary axis.,0,0.708,0.0,0.0,0.0,0.0004,0.1248,-0.005,0.0,"Non-cancer illness code, self-reported | Array 1__hypothyroidism",1.0,90531,"Non-cancer illness code, self-reported | Array 1__hypothyroidism < 0.29",0.12,0.12,2
"M19.97 - Arthrosis, unspecified (Ankle and foot)",C0022408,Arthropathy,Arthropathy. Diseases involving the JOINTS.,0,0.432,0.0,0.0,0.0,0.0004,0.1054,0.002,0.0001,"M19.97 - Arthrosis, unspecified (Ankle and foot)",1.0,91367,"-6.50 <= M19.97 - Arthrosis, unspecified (Ankle and foot) < 13.00",0.03,0.03,2
"M19.97 - Arthrosis, unspecified (Ankle and foot)",C0029408,Degenerative polyarthritis,"Degenerative polyarthritis. A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.",0,0.289,0.0,0.0,0.0,0.0004,0.1054,0.002,0.0001,"M19.97 - Arthrosis, unspecified (Ankle and foot)",1.0,91367,"-6.50 <= M19.97 - Arthrosis, unspecified (Ankle and foot) < 13.00",0.03,0.03,2
"M19.97 - Arthrosis, unspecified (Ankle and foot)",C4760573,Arthrosis,Arthrosis. ,0,0.451,0.0,0.0,0.0,0.0004,0.1054,0.002,0.0001,"M19.97 - Arthrosis, unspecified (Ankle and foot)",1.0,91367,"-6.50 <= M19.97 - Arthrosis, unspecified (Ankle and foot) < 13.00",0.03,0.03,99
"M19.97 - Arthrosis, unspecified (Ankle and foot)",C0870018,Ankle and Foot,Ankle and Foot. ,0,0.472,0.0,0.0,0.0,0.0004,0.1054,0.002,0.0001,"M19.97 - Arthrosis, unspecified (Ankle and foot)",1.0,91367,"-6.50 <= M19.97 - Arthrosis, unspecified (Ankle and foot) < 13.00",0.03,0.03,2
medication 2mg,C3840903,Medication 2,Medication 2. ,0,0.629,0.0,0.0,0.0,0.0004,0.0405,0.007,0.0,Treatment/medication code | Array 0__2mg,1.0,91420,Treatment/medication code | Array 0__2mg < 0.46,0.01,0.01,99
Chronic ulcer of skin,C0333297,Chronic ulcer,Chronic ulcer. ,0,0.818,0.0,0.0,0.0,0.0004,0.1227,0.009,0.0002,Chronic ulcer of skin,1.0,90946,-3.30 <= Chronic ulcer of skin < 1.10,0.04,0.04,2
Chronic ulcer of skin,C0444099,Skin Specimen,Skin Specimen. ,0,0.422,0.0,0.0,0.0,0.0004,0.1227,0.009,0.0002,Chronic ulcer of skin,1.0,90946,-3.30 <= Chronic ulcer of skin < 1.10,0.04,0.04,2
Chronic ulcer of skin,C1123023,Skin,Skin. The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.,0,0.532,0.0,0.0,0.0,0.0004,0.1227,0.009,0.0002,Chronic ulcer of skin,1.0,90946,-3.30 <= Chronic ulcer of skin < 1.10,0.04,0.04,2
dietary changes in the last 5 years Prefer not to answer,C0392747,Changing,Changing. The act of alteration or modification; changed or altered in form or character.,0,0.267,0.0,1.0,0.3,0.0004,0.013,0.008,0.0,Major dietary changes in the last 5 years_Prefer not to answer,1.0,91330,Major dietary changes in the last 5 years_Prefer not to answer < 0.50,0.11,0.11,99
dietary changes in the last 5 years Prefer not to answer,C0443172,Changed status,Changed status. ,0,0.204,0.0,1.0,0.3,0.0004,0.013,0.008,0.0,Major dietary changes in the last 5 years_Prefer not to answer,1.0,91330,Major dietary changes in the last 5 years_Prefer not to answer < 0.50,0.11,0.11,99
chronic,C1555457,Provision of recurring care for chronic illness,Provision of recurring care for chronic illness. <p>Provision of recurring care for chronic illness.</p>,0,0.474,0.0,0.0,0.0,0.0004,0.1676,0.006,0.0,"Non-cancer illness code, self-reported | Array 3__chronic",1.0,91265,"Non-cancer illness code, self-reported | Array 3__chronic < 0.14",0.03,0.03,99
Other disorders of male genital organs,C1706428,Male Phenotype,"Male Phenotype. An animal who is observed by researcher or clinician to be male, the sex that ordinarily produces sperm.",0,0.243,0.0,1.0,0.3,0.0003,0.1992,-0.004,0.0001,Other disorders of male genital organs,1.0,90778,-0.17 <= Other disorders of male genital organs < 8.00,0.04,0.04,99
Other disorders of male genital organs,C0017420,Genitalia,Genitalia. The external and internal organs involved in the functions of REPRODUCTION.,0,0.593,0.0,1.0,0.3,0.0003,0.1992,-0.004,0.0001,Other disorders of male genital organs,1.0,90778,-0.17 <= Other disorders of male genital organs < 8.00,0.04,0.04,2
uterine polyps,C0156369,Uterine Polyp,Uterine Polyp. A benign protruding lesion arising either from the endometrial cavity (endometrial polyp) or the endocervix (endocervical polyp). It may occasionally recur following complete resection.,0,0.911,0.0,0.0,0.0,0.0003,0.0989,0.005,0.0,"Non-cancer illness code, self-reported | Array 2__uterine polyps",1.0,91558,"Non-cancer illness code, self-reported | Array 2__uterine polyps < 0.34",0.08,0.08,2
Job code at visit distribution,C0037775,Spatial Distribution,"Spatial Distribution. The placement, arrangement of instance of entities within a space.",0,0.157,0.0,0.0,0.0,0.0003,0.0831,0.006,0.0,Job code at visit__distribution,1.0,91227,Job code at visit__distribution < 0.23,-0.06,0.03,2
Job code at visit distribution,C1704711,Distribution,Distribution. The act of distributing or spreading or apportioning.,0,0.16,0.0,0.0,0.0,0.0003,0.0831,0.006,0.0,Job code at visit__distribution,1.0,91227,Job code at visit__distribution < 0.23,-0.06,0.03,99
angina,C0002962,Angina Pectoris,"Angina Pectoris. The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.",0,0.688,0.0,0.0,0.0,0.0003,0.0,0.038,0.0006,"Non-cancer illness code, self-reported | Array 1__angina",1.74,2130,"Non-cancer illness code, self-reported | Array 1__angina >= 0.50",0.12,0.12,2
Calculus of bile duct,C0006736,Calculi,"Calculi. An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.",0,0.602,0.0,0.0,0.0,0.0003,0.1227,0.004,0.0001,Calculus of bile duct,1.0,91266,-16.00 <= Calculus of bile duct < 6.80,0.02,0.02,2
Calculus of bile duct,C0392333,Mathematical Calculus,Mathematical Calculus. ,0,0.156,0.0,0.0,0.0,0.0003,0.1227,0.004,0.0001,Calculus of bile duct,1.0,91266,-16.00 <= Calculus of bile duct < 6.80,0.02,0.02,99
Calculus of bile duct,C0005400,Bile duct structure,"Bile duct structure. The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.",0,0.56,0.0,0.0,0.0,0.0003,0.1227,0.004,0.0001,Calculus of bile duct,1.0,91266,-16.00 <= Calculus of bile duct < 6.80,0.02,0.02,2
Pulmonary heart disease,C0034072,Cor pulmonale,"Cor pulmonale. Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.",0,0.679,0.0,0.0,0.0,0.0003,0.0125,-0.007,0.0001,Pulmonary heart disease,1.0,90244,-0.40 <= Pulmonary heart disease < 2.90,0.01,0.01,2
"Medication for cholesterol, blood pressure or diabetes Medication Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.005,0.0,0.055,0.0014,"Medication for cholesterol, blood pressure or diabetes Medication_Blood pressure medication",1.49,9276,"Medication for cholesterol, blood pressure or diabetes Medication_Blood pressure medication >= 0.50",-0.07,-0.07,2
Mental health conditions ever diagnosed by a professional group,,,,0,1.0,0.0,0.0,0.0,0.0268,0.0,-0.038,0.0022,Mental health conditions ever diagnosed by a professional__group,1.07,66419,Mental health conditions ever diagnosed by a professional__group < 0.01,-0.04,-0.04,2
medication arcoxia,,,,0,1.0,0.0,0.0,0.0,0.0008,0.0,0.016,0.0001,Treatment/medication code | Array 0__arcoxia,1.0,91515,Treatment/medication code | Array 0__arcoxia < 0.24,0.02,0.02,2
Home area population density - urban or rural Scotland - Large Urban Area,,,,0,1.0,0.0,0.0,0.0,0.0804,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.03,0.08,2
Concentration of Large LDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0008,0.0,-0.024,0.0683,Concentration of Large LDL Particles,1.16,7437,-3.50 <= Concentration of Large LDL Particles < -0.85,-0.1,-0.1,2
Neuroticism score,,,,0,1.0,0.0,0.0,0.0,0.0076,0.2536,0.003,0.0001,Neuroticism score,1.13,6228,0.23 <= Neuroticism score < 0.58,-0.05,-0.05,2
medication tablet,,,,0,1.0,0.0,0.0,0.0,0.0071,0.001,-0.008,0.001,Treatment/medication code | Array 0__tablet,1.06,2375,0.26 <= Treatment/medication code | Array 0__tablet < 0.41,0.01,0.01,2
Complications of transplants and reattached limbs,,,,0,1.0,0.0,0.0,0.0,0.0006,0.1044,-0.002,0.0002,Complications of transplants and reattached limbs,0.99,89350,-1.40 <= Complications of transplants and reattached limbs < 0.39,0.06,0.06,2
"M19.99 - Arthrosis, unspecified (Site unspecified)",,,,0,1.0,0.0,0.0,0.0,0.0012,0.7569,0.004,0.0003,"M19.99 - Arthrosis, unspecified (Site unspecified)",0.99,89932,"-0.86 <= M19.99 - Arthrosis, unspecified (Site unspecified) < 0.02",0.15,0.15,2
Concentration of Small LDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0018,0.0,-0.017,0.0486,Concentration of Small LDL Particles,1.0,80534,-2.80 <= Concentration of Small LDL Particles < 0.19,-0.11,-0.11,2
"Long-standing illness, disability or infirmity",,,,0,1.0,0.0,0.0,0.0,0.0384,0.0,-0.087,0.0038,"Long-standing illness, disability or infirmity_No",1.28,42073,"Long-standing illness, disability or infirmity_No < 0.50",0.0,0.0,2
Cholesterol in Very Small VLDL,,,,0,1.0,0.0,0.0,0.0,0.0014,0.0,-0.029,0.0525,Cholesterol in Very Small VLDL,1.29,6102,-4.60 <= Cholesterol in Very Small VLDL < -1.30,-0.11,-0.11,2
Vascular/heart problems diagnosed by doctor Angina,,,,0,1.0,0.0,0.0,0.0,0.0004,0.078,-0.006,0.0,Vascular/heart problems diagnosed by doctor_Angina,1.0,90076,Vascular/heart problems diagnosed by doctor_Angina < 0.50,0.08,0.08,2
"Qualifications A levels/AS levels or equivalent|O levels/GCSEs or equivalent|Other professional qualifications eg: nursing, teaching",,,,0,1.0,0.0,0.0,0.0,0.0014,0.0004,-0.012,0.0001,"Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|Other professional qualifications eg: nursing, teaching",1.0,90185,"Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|Other professional qualifications eg: nursing, teaching < 0.50",-0.08,-0.08,2
Job code at visit officers,,,,0,1.0,0.0,0.0,0.0,0.0005,0.0166,-0.009,0.0001,Job code at visit__officers,1.01,88472,Job code at visit__officers < 0.09,-0.06,0.02,2
Job code at visit sales,,,,0,1.0,0.0,0.0,0.0,0.0007,0.0298,0.007,0.0001,Job code at visit__sales,1.26,1227,0.41 <= Job code at visit__sales < 0.45,-0.05,-0.04,2
"Medication for cholesterol, blood pressure or diabetes Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.0005,0.0,0.055,0.0014,"Medication for cholesterol, blood pressure or diabetes_Blood pressure medication",1.49,9276,"Medication for cholesterol, blood pressure or diabetes_Blood pressure medication >= 0.50",-0.08,-0.08,2
"Z13.9 - Special screening examination, unspecified",,,,0,1.0,0.0,0.0,0.0,0.0003,0.0989,-0.002,0.0002,"Z13.9 - Special screening examination, unspecified",1.0,91232,"Z13.9 - Special screening examination, unspecified >= -0.92",0.02,0.02,2
Qualifications A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0109,-0.008,0.0,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,1.0,90738,Qualifications_A levels/AS levels or equivalent|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent < 0.50,-0.01,-0.01,2
"dietary changes in the last 5 years Yes, because of other reasons",,,,0,1.0,0.0,0.0,0.0,0.003,0.0065,-0.009,0.0,"Major dietary changes in the last 5 years_Yes, because of other reasons",1.02,67117,"Major dietary changes in the last 5 years_Yes, because of other reasons < 0.50",0.11,0.11,2
"I48.9 - Atrial fibrillation and atrial flutter, unspecified",,,,0,1.0,0.0,0.0,0.0,0.0057,0.4092,0.008,0.0004,"I48.9 - Atrial fibrillation and atrial flutter, unspecified",0.99,89925,"-2.70 <= I48.9 - Atrial fibrillation and atrial flutter, unspecified < 1.10",0.06,0.13,2
Basophill count,,,,0,1.0,0.0,0.0,0.0,0.0162,0.0,0.023,0.0009,Basophill count,1.34,2006,1.70 <= Basophill count < 5.80,-0.03,-0.03,2
Mental health conditions ever diagnosed by a professional group depression,,,,0,1.0,0.0,0.0,0.0,0.0006,0.0,-0.015,0.001,Mental health conditions ever diagnosed by a professional__group depression,1.01,87484,Mental health conditions ever diagnosed by a professional__group depression < 0.15,0.03,0.03,2
Pulse wave reflection index,,,,0,1.0,0.0,0.0,0.0,0.0058,0.6607,-0.001,0.0009,Pulse wave reflection index,1.07,4830,-2.20 <= Pulse wave reflection index < -0.67,-0.01,-0.01,2
Meat substitutes - vegetarian,,,,0,1.0,0.0,0.0,0.0,0.0048,0.255,0.004,0.0001,Meat substitutes - vegetarian,1.01,80042,-0.18 <= Meat substitutes - vegetarian < 3.10,0.01,0.16,2
Alcohol intake frequency. Once or twice a week,,,,0,1.0,0.0,0.0,0.0,0.001,0.0,-0.025,0.0003,Alcohol intake frequency._Once or twice a week,1.04,68558,Alcohol intake frequency._Once or twice a week < 0.50,0.05,0.07,2
Vascular/heart problems diagnosed by doctor None of the above,,,,0,1.0,0.0,0.0,0.0,0.048,0.0,-0.115,0.0066,Vascular/heart problems diagnosed by doctor_None of the above,1.38,41874,Vascular/heart problems diagnosed by doctor_None of the above < 0.50,-0.02,-0.02,2
Overall health rating Good,,,,0,1.0,0.0,0.0,0.0,0.0024,0.0,-0.048,0.0012,Overall health rating_Good,1.15,43190,Overall health rating_Good < 0.50,-0.08,-0.08,2
Job code at visit assistants,,,,0,1.0,0.0,0.0,0.0,0.0027,0.016,-0.009,0.0001,Job code at visit__assistants,1.01,87221,Job code at visit__assistants < 0.11,-0.01,0.0,2
Rash and other nonspecific skin eruption,,,,0,1.0,0.0,0.0,0.0,0.001,0.0733,-0.004,0.0002,Rash and other nonspecific skin eruption,1.0,90827,-1.00 <= Rash and other nonspecific skin eruption < 0.34,-0.09,-0.09,2
Job code at visit distribution,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0831,0.006,0.0,Job code at visit__distribution,1.0,91227,Job code at visit__distribution < 0.23,-0.06,0.03,2
medication garlic,,,,0,1.0,0.0,0.0,0.0,0.0003,0.1469,-0.005,0.0,Treatment/medication code | Array 0__garlic,1.0,91412,Treatment/medication code | Array 0__garlic < 0.32,0.03,0.04,2
Average Diameter for HDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0006,0.0,-0.021,0.03,Average Diameter for HDL Particles,1.15,7281,-3.00 <= Average Diameter for HDL Particles < -0.96,0.01,0.01,2
"Medication for cholesterol, blood pressure or diabetes Medication Cholesterol lowering medication|Blood pressure medication|Insulin",,,,0,1.0,0.0,0.0,0.0,0.0004,0.0237,0.007,0.0,"Medication for cholesterol, blood pressure or diabetes Medication_Cholesterol lowering medication|Blood pressure medication|Insulin",1.21,1006,"Medication for cholesterol, blood pressure or diabetes Medication_Cholesterol lowering medication|Blood pressure medication|Insulin >= 0.50",-0.08,-0.03,2
Job code at visit teaching,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0,-0.022,0.0003,Job code at visit__teaching,1.01,87979,Job code at visit__teaching < 0.12,-0.04,-0.01,2
Vascular/heart problems diagnosed by doctor High blood pressure,,,,0,1.0,0.0,0.0,0.0,0.0027,0.0,0.082,0.0032,Vascular/heart problems diagnosed by doctor_High blood pressure,1.34,30845,Vascular/heart problems diagnosed by doctor_High blood pressure >= 0.50,0.02,0.02,2
Job code at visit professionals,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0,-0.022,0.0004,Job code at visit__professionals,1.02,85437,Job code at visit__professionals < 0.11,-0.07,-0.0,2
dietary changes in the last 5 years,,,,0,1.0,0.0,0.0,0.0,0.0036,0.0,-0.033,0.0005,Major dietary changes in the last 5 years_No,1.11,39187,Major dietary changes in the last 5 years_No < 0.50,0.08,0.08,2
Fluid intelligence score,,,,0,1.0,0.0,0.0,0.0,0.0006,0.0108,-0.008,0.0001,Fluid intelligence score,1.26,1102,-3.60 <= Fluid intelligence score < -2.80,-0.1,-0.1,2
Concentration of Medium LDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0027,0.0,-0.017,0.0594,Concentration of Medium LDL Particles,1.38,1141,-3.70 <= Concentration of Medium LDL Particles < -2.80,-0.01,-0.01,2
Job code at visit teaching professionals,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0,-0.022,0.0003,Job code at visit__teaching professionals,1.01,87979,Job code at visit__teaching professionals < 0.12,-0.06,-0.01,2
avMSE,,,,0,1.0,0.0,0.0,0.0,0.0021,0.7352,-0.001,0.0411,avMSE,1.12,6630,-4.00 <= avMSE < -0.09,0.1,0.1,2
M79.66 - Pain in limb (Lower leg),,,,0,1.0,0.0,0.0,0.0,0.0016,0.1388,0.006,0.0002,M79.66 - Pain in limb (Lower leg),1.0,90618,-0.49 <= M79.66 - Pain in limb (Lower leg) < 0.39,0.06,0.06,2
"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones Cholesterol lowering medication|Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.0008,0.0,0.03,0.0004,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Cholesterol lowering medication|Blood pressure medication",1.5,2844,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Cholesterol lowering medication|Blood pressure medication >= 0.50",-0.09,-0.09,2
Circulatory disease NEC,,,,0,1.0,0.0,0.0,0.0,0.0015,0.039,-0.002,0.0007,Circulatory disease NEC,1.39,1979,-4.80 <= Circulatory disease NEC < -0.20,0.03,0.03,2
Age angina diagnosed infrequent,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0,0.021,0.0002,Age angina diagnosed_infrequent_,1.0,91445,Age angina diagnosed_infrequent_ < 0.50,0.13,0.16,2
medication adalat 5mg,,,,0,1.0,0.0,0.0,0.0,0.0005,0.0,0.014,0.0001,Treatment/medication code | Array 0__adalat 5mg,1.0,91198,Treatment/medication code | Array 0__adalat 5mg < 0.24,-0.01,-0.01,2
Age diabetes diagnosed,,,,0,1.0,0.0,0.0,0.0,0.0068,0.0,0.027,0.0012,Age diabetes diagnosed,1.52,1339,Age diabetes diagnosed >= 2.50,-0.05,-0.05,2
Home area population density - urban or rural England/Wales - Urban - less sparse,,,,0,1.0,0.0,0.0,0.0,0.004,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.05,0.06,2
M54.56 - Low back pain (Lumbar region),,,,0,1.0,0.0,0.0,0.0,0.0015,0.0004,0.012,0.0002,M54.56 - Low back pain (Lumbar region),1.0,91086,-17.00 <= M54.56 - Low back pain (Lumbar region) < 0.75,0.01,0.01,2
M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,,,,0,1.0,0.0,0.0,0.0,0.0005,0.0877,0.007,0.0002,M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,1.0,90946,-9.00 <= M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy < 4.40,-0.01,-0.01,2
dietary changes in the last 5 years Prefer not to answer,,,,0,1.0,0.0,0.0,0.0,0.0004,0.013,0.008,0.0,Major dietary changes in the last 5 years_Prefer not to answer,1.0,91330,Major dietary changes in the last 5 years_Prefer not to answer < 0.50,0.11,0.11,2
Mental health conditions ever diagnosed by a professional depression,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0,-0.015,0.0014,Mental health conditions ever diagnosed by a professional__depression,1.01,87118,Mental health conditions ever diagnosed by a professional__depression < 0.08,-0.04,-0.04,2
Job code at visit vocational,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0421,-0.006,0.0,Job code at visit__vocational,1.0,91258,Job code at visit__vocational < 0.19,-0.05,0.01,2
M47.82 - Other spondylosis (Cervical region),,,,0,1.0,0.0,0.0,0.0,0.001,0.1002,-0.005,0.0002,M47.82 - Other spondylosis (Cervical region),1.0,90852,-0.73 <= M47.82 - Other spondylosis (Cervical region) < 0.34,0.14,0.19,2
Home area population density - urban or rural Scotland - Other Urban Area,,,,0,1.0,0.0,0.0,0.0,0.0126,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.03,0.05,2
Apolipoprotein A Blood biochemistry,,,,0,1.0,0.0,0.0,0.0,0.054,0.0127,-0.012,0.0102,Apolipoprotein A Blood biochemistry,1.15,7980,-2.10 <= Apolipoprotein A Blood biochemistry < -1.20,-0.07,-0.07,2
Z92.1 - Personal history of long-term (current) use of anticoagulants,,,,0,1.0,0.0,0.0,0.0,0.0187,0.0112,0.001,0.0017,Z92.1 - Personal history of long-term (current) use of anticoagulants,1.66,2685,Z92.1 - Personal history of long-term (current) use of anticoagulants >= 1.30,0.09,0.11,2
Arm fat percentage,,,,0,1.0,0.0,0.0,0.0,0.0467,0.2027,0.016,0.0041,Arm fat percentage (left),1.18,16282,-0.01 <= Arm fat percentage (left) < 0.61,0.01,0.01,2
Cholesterol in IDL,,,,0,1.0,0.0,0.0,0.0,0.0038,0.0,-0.038,0.0679,Cholesterol in IDL,1.76,1026,-4.60 <= Cholesterol in IDL < -3.20,-0.05,-0.05,2
Average Diameter for VLDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0014,0.0,0.031,0.0285,Average Diameter for VLDL Particles,1.87,986,3.30 <= Average Diameter for VLDL Particles < 5.90,-0.02,-0.02,2
Other serious medical condition/disability diagnosed by doctor,,,,0,1.0,0.0,0.0,0.0,0.0058,0.0,-0.062,0.0018,Other serious medical condition/disability diagnosed by doctor_No,1.3,25187,Other serious medical condition/disability diagnosed by doctor_No < 0.50,-0.11,-0.11,2
Z87.4 - Personal history of diseases of the genito-urinary system,,,,0,1.0,0.0,0.0,0.0,0.0016,0.7627,0.003,0.0002,Z87.4 - Personal history of diseases of the genito-urinary system,0.99,89488,-2.00 <= Z87.4 - Personal history of diseases of the genito-urinary system < 0.02,0.02,0.02,2
Average Diameter for LDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0009,0.0,-0.027,0.0039,Average Diameter for LDL Particles,1.21,7036,-5.50 <= Average Diameter for LDL Particles < -0.75,-0.06,-0.06,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.0009,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",-0.08,-0.08,2
Concentration of Very Large HDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0016,0.0,-0.032,0.0566,Concentration of Very Large HDL Particles,1.36,1434,-2.80 <= Concentration of Very Large HDL Particles < -2.10,-0.04,-0.04,2
Townsend deprivation index at recruitment,,,,0,1.0,0.0,0.0,0.0,0.0061,0.0,0.025,0.0094,Townsend deprivation index at recruitment,1.19,10276,1.40 <= Townsend deprivation index at recruitment < 2.90,-0.08,0.12,2
Z96.6 - Presence of orthopaedic joint implants,,,,0,1.0,0.0,0.0,0.0,0.0008,0.0006,-0.007,0.0003,Z96.6 - Presence of orthopaedic joint implants,1.33,1458,-6.30 <= Z96.6 - Presence of orthopaedic joint implants < -0.35,0.06,0.07,2
Mental health conditions ever diagnosed by a professional group group,,,,0,1.0,0.0,0.0,0.0,0.0062,0.0,-0.036,0.001,Mental health conditions ever diagnosed by a professional__group group,1.06,68835,Mental health conditions ever diagnosed by a professional__group group < 0.03,0.02,0.02,2
Number of treatments/medications taken,,,,0,1.0,0.0,0.0,0.0,0.0825,0.0,0.136,0.01,Number of treatments/medications taken,2.16,4076,Number of treatments/medications taken >= 2.00,-0.01,-0.01,2
Number of self-reported non-cancer illnesses,,,,0,1.0,0.0,0.0,0.0,0.0883,0.0,0.138,0.0101,Number of self-reported non-cancer illnesses,2.36,1149,Number of self-reported non-cancer illnesses >= 3.00,0.08,0.08,2
Job code at visit education,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0,-0.019,0.0002,Job code at visit__education,1.01,88208,Job code at visit__education < 0.12,-0.04,-0.0,2
M25.56 - Pain in joint (Lower leg),,,,0,1.0,0.0,0.0,0.0,0.0012,0.0548,0.008,0.0003,M25.56 - Pain in joint (Lower leg),0.99,90802,-0.65 <= M25.56 - Pain in joint (Lower leg) < 0.29,-0.01,-0.01,2
Job code at visit chartered,,,,0,1.0,0.0,0.0,0.0,0.0005,0.0684,-0.006,0.0,Job code at visit__chartered,1.0,90183,Job code at visit__chartered < 0.14,-0.02,-0.01,2
Peripheral enthesopathies and allied syndromes,,,,0,1.0,0.0,0.0,0.0,0.0006,0.1883,0.006,0.0004,Peripheral enthesopathies and allied syndromes,0.99,89222,-2.10 <= Peripheral enthesopathies and allied syndromes < 0.90,-0.02,-0.02,2
Concentration of Medium HDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0007,0.0026,0.004,0.06,Concentration of Medium HDL Particles,1.18,1085,3.70 <= Concentration of Medium HDL Particles < 8.70,0.04,0.04,2
Z09.0 - Follow-up examination after surgery for other conditions,,,,0,1.0,0.0,0.0,0.0,0.0005,0.1897,-0.005,0.0002,Z09.0 - Follow-up examination after surgery for other conditions,0.99,90275,-0.25 <= Z09.0 - Follow-up examination after surgery for other conditions < 4.30,-0.03,-0.03,2
"M15.9 - Polyarthrosis, unspecified",,,,0,1.0,0.0,0.0,0.0,0.004,0.0127,0.01,0.0002,"M15.9 - Polyarthrosis, unspecified",0.99,90102,"-0.16 <= M15.9 - Polyarthrosis, unspecified < 0.86",0.1,0.1,2
Z51.5 - Palliative care,,,,0,1.0,0.0,0.0,0.0,0.0241,0.7013,-0.004,0.0013,Z51.5 - Palliative care,1.02,90035,-0.46 <= Z51.5 - Palliative care < 0.85,0.18,0.18,2
Qualifications NVQ or HND or HNC or equivalent,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0026,0.01,0.0,Qualifications_NVQ or HND or HNC or equivalent,1.1,7423,Qualifications_NVQ or HND or HNC or equivalent >= 0.50,-0.02,-0.02,2
Overall health rating Fair,,,,0,1.0,0.0,0.0,0.0,0.0006,0.0,0.05,0.0012,Overall health rating_Fair,1.24,25623,Overall health rating_Fair >= 0.50,-0.1,-0.1,2
"dietary changes in the last 5 years Yes, because of illness",,,,0,1.0,0.0,0.0,0.0,0.0005,0.0,0.054,0.0013,"Major dietary changes in the last 5 years_Yes, because of illness",1.37,14262,"Major dietary changes in the last 5 years_Yes, because of illness >= 0.50",0.11,0.11,2
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,,,,0,1.0,0.0,0.0,0.0,0.0041,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.05,0.08,2
Other ill-defined and unknown causes of morbidity and mortality,,,,0,1.0,0.0,0.0,0.0,0.0043,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.07,0.07,2
Alcohol intake frequency. Three or four times a week,,,,0,1.0,0.0,0.0,0.0,0.0024,0.0042,0.009,0.0,Alcohol intake frequency._Three or four times a week,1.05,21264,Alcohol intake frequency._Three or four times a week >= 0.50,0.04,0.12,2
Concentration of HDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0008,0.1116,0.002,0.0387,Concentration of HDL Particles,1.21,2381,Concentration of HDL Particles < -2.30,-0.04,-0.04,2
Overall health rating Excellent,,,,0,1.0,0.0,0.0,0.0,0.0012,0.0,-0.046,0.0012,Overall health rating_Excellent,1.05,81543,Overall health rating_Excellent < 0.50,-0.1,-0.1,2
medication cilexetil,,,,0,1.0,0.0,0.0,0.0,0.0005,0.0972,0.005,0.0,Treatment/medication code | Array 0__cilexetil,1.0,91269,Treatment/medication code | Array 0__cilexetil < 0.29,0.03,0.03,2
Cancer of prostate,,,,0,1.0,0.0,0.0,0.0,0.005,0.7964,0.0,0.0003,Cancer of prostate,1.01,88093,-0.14 <= Cancer of prostate < 0.15,0.23,0.23,2
medication diclofenac,,,,0,1.0,0.0,0.0,0.0,0.0036,0.0,0.015,0.0001,Treatment/medication code | Array 0__diclofenac,1.0,90740,Treatment/medication code | Array 0__diclofenac < 0.37,0.0,0.0,2
medication capsule,,,,0,1.0,0.0,0.0,0.0,0.0011,0.0,-0.014,0.0007,Treatment/medication code | Array 0__capsule,1.01,88303,Treatment/medication code | Array 0__capsule < 0.24,0.08,0.11,2
"M19.97 - Arthrosis, unspecified (Ankle and foot)",,,,0,1.0,0.0,0.0,0.0,0.0004,0.1054,0.002,0.0001,"M19.97 - Arthrosis, unspecified (Ankle and foot)",1.0,91367,"-6.50 <= M19.97 - Arthrosis, unspecified (Ankle and foot) < 13.00",0.03,0.03,2
(HDL) high density lipoprotein cholesterol genetic risk,,,,0,1.0,0.0,0.0,0.0,0.0136,0.0,-0.021,0.307,(HDL) high density lipoprotein cholesterol genetic risk,1.15,7182,(HDL) high density lipoprotein cholesterol genetic risk < -1.40,0.03,0.03,2
Concentration of Very Small VLDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0015,0.001,-0.01,0.066,Concentration of Very Small VLDL Particles,1.12,7399,-3.90 <= Concentration of Very Small VLDL Particles < -0.95,-0.08,-0.08,2
Concentration of Medium VLDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0014,0.1198,-0.007,0.0656,Concentration of Medium VLDL Particles,0.99,89332,-2.90 <= Concentration of Medium VLDL Particles < 3.90,-0.01,-0.01,2
Y83.8 - Other surgical procedures,,,,0,1.0,0.0,0.0,0.0,0.0008,0.0399,0.008,0.0002,Y83.8 - Other surgical procedures,0.99,89841,-2.00 <= Y83.8 - Other surgical procedures < 0.00,0.04,0.04,2
Concentration of Small HDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0009,0.0,0.01,0.0542,Concentration of Small HDL Particles,1.44,1117,2.10 <= Concentration of Small HDL Particles < 2.70,-0.04,-0.04,2
LDL direct Blood biochemistry,,,,0,1.0,0.0,0.0,0.0,0.0458,0.0,-0.06,0.0297,LDL direct Blood biochemistry,1.34,9470,-2.70 <= LDL direct Blood biochemistry < -1.30,-0.12,-0.12,2
Z53.8 - Procedure not carried out for other reasons,,,,0,1.0,0.0,0.0,0.0,0.0067,0.1478,-0.006,0.0003,Z53.8 - Procedure not carried out for other reasons,1.47,1325,-5.30 <= Z53.8 - Procedure not carried out for other reasons < -0.68,0.13,0.13,2
Qualifications College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0001,-0.013,0.0001,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,1.01,88450,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent < 0.50,-0.02,0.0,2
"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.0013,0.0,0.014,0.0001,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Blood pressure medication",1.23,3018,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Blood pressure medication >= 0.50",-0.09,-0.09,2
medication alfacalcidol,,,,0,1.0,0.0,0.0,0.0,0.0006,0.0,0.038,0.0004,Treatment/medication code | Array 0__alfacalcidol,1.0,91465,Treatment/medication code | Array 0__alfacalcidol < 0.50,-0.11,-0.11,2
"N18.3 - Chronic kidney disease, stage",,,,0,1.0,0.0,0.0,0.0,0.0073,0.1787,0.012,0.0011,"N18.3 - Chronic kidney disease, stage 3",0.98,90180,"-0.83 <= N18.3 - Chronic kidney disease, stage 3 < 1.20",0.16,0.16,2
Overall health rating Poor,,,,0,1.0,0.0,0.0,0.0,0.0026,0.0,0.056,0.0014,Overall health rating_Poor,1.6,6756,Overall health rating_Poor >= 0.50,-0.07,-0.07,2
Alcohol intake frequency. One to three times a month,,,,0,1.0,0.0,0.0,0.0,0.0026,0.0,-0.028,0.0004,Alcohol intake frequency._One to three times a month,1.03,82577,Alcohol intake frequency._One to three times a month < 0.50,0.05,0.08,2
Hip circumference,,,,0,1.0,0.0,0.0,0.0,0.0954,0.0,0.022,0.0023,Hip circumference,1.21,1302,2.80 <= Hip circumference < 4.50,-0.05,-0.05,2
Concentration of IDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0025,0.0,-0.033,0.0604,Concentration of IDL Particles,1.43,2252,-3.80 <= Concentration of IDL Particles < -2.40,0.04,0.04,2
Job code at visit nurses,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0,-0.014,0.0001,Job code at visit__nurses,1.0,90893,Job code at visit__nurses < 0.25,-0.05,-0.05,2
Other serious medical condition/disability diagnosed by doctor Yes - you will be asked about this later by an interviewer,,,,0,1.0,0.0,0.0,0.0,0.0019,0.0,0.057,0.0016,Other serious medical condition/disability diagnosed by doctor_Yes - you will be asked about this later by an interviewer,1.3,22954,Other serious medical condition/disability diagnosed by doctor_Yes - you will be asked about this later by an interviewer >= 0.50,-0.02,-0.02,2
